Baxalta Incorporated et al v. Genentech, Inc. et al > Documents

Date Field	Doc. No.	Description (Pages)
Apr 29, 2022	581	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Marissa C.M. Doran as co-counsel.. (Balick, Steven)
Mar 31, 2022	N/A	Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. � 652(b). (Taylor, Daniel)
Feb 24, 2022	580	Appeal Transcript Request (1) Docket Text: TRANSCRIPT REQUEST by Baxalta GmbH, Baxalta Incorporated TRANSCRIPT IS ALREADY ON FILE (Dudash, Amy)
Feb 10, 2022	579	USCA Notice of Docketing ROA (4) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [578] Notice of Appeal (Federal Circuit) filed by Baxalta GmbH and Baxalta Incorporated. USCA Case Number 22-1461. (nmg)
Feb 9, 2022	N/A	Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [578] Notice of Appeal (Federal Circuit). (srs)
Feb 8, 2022	578	Notice of Appeal* (1)
Feb 8, 2022	N/A	APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [578] Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. ( Filing fee $505, receipt number ADEDC-3798835.) (Dudash, Amy)
Feb 8, 2022	578	Notice of Appeal (Federal Circuit) (2) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [574] Order on Motion for Summary Judgment, [573] Memorandum Opinion . Appeal filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 19, 2022	N/A	Remark (0) Docket Text: Remark: D.I. [573] Memorandum Opinion UNSEALED per Oral Order D.I. 577 (myr)
Jan 19, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER: In light of [576] the parties' January 18, 2022, Letter informing the court that they have not requested redactions to the January 13, 2022, Memorandum Opinion, the clerk is hereby directed to unseal the Memorandum Opinion [573] in its entirety. Signed by Judge Timothy Belcher Dyk on 1/19/2022. (myr)
Jan 18, 2022	576	Letter (1) Docket Text: Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding the Parties' Joint Position Concerning Redaction of the Court's January 13, 2022 Memorandum Opinion (D.I 573). (Balick, Steven)
Jan 13, 2022	573	Memorandum Opinion (Memorandum Opinion) (30) Docket Text: [UNSEALED] MEMORANDUM OPINION. Signed by Judge Timothy Belcher Dyk on 1/13/2022.This order has been emailed to local counsel. (myr)
Jan 13, 2022	574	Order on Motion for Summary Judgment (1) Docket Text: ORDER granting [407] Genentech Inc.'s Motion for Summary Judgment. See the accompanying Memorandum Opinion for additional details. The parties shall meet and confer and propose any redactions to the Memorandum Opinion on or before January 18, 2022. Signed by Judge Timothy Belcher Dyk on 1/13/2022. (myr)
Jan 13, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER. In light of the court's [574] Order granting Genentech Inc.'s Motion for Summary Judgment, the parties' outstanding pre-trial motions, ECF Nos. 438-453, 455, 457-460, are hereby denied as moot. Entered by Judge Timothy Belcher Dyk on 1/13/2022. (nmg)
Jan 12, 2022	572	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Alexander F. Atkins as co-counsel.. (Mayo, Andrew)
Jan 5, 2022	571	Order on Motion to Seal (1) Docket Text: ORDER denying [435] Motion to Seal. (See Order for further details). Signed by Judge Timothy Belcher Dyk on 01/05/2022. (smg)
Jan 4, 2022	563	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [520] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Jan 4, 2022	563	Redacted Document (Exhibit 1) (6) Docket Text: REDACTED VERSION of [520] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Jan 4, 2022	564	Redacted Document (5) Docket Text: REDACTED VERSION of [522] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 4, 2022	565	Redacted Document (5) Docket Text: REDACTED VERSION of [523] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 4, 2022	566	Redacted Document (Main Document) (8) Docket Text: REDACTED VERSION of [524] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Jan 4, 2022	566	Redacted Document (Exhibit 1) (20) Docket Text: REDACTED VERSION of [524] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Jan 4, 2022	567	Redacted Document (13) Docket Text: REDACTED VERSION of [526] Reply Brief by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 4, 2022	568	Redacted Document (Main Document) (11) Docket Text: REDACTED VERSION of [527] Reply Brief by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Jan 4, 2022	568	Redacted Document (Exhibit 1) (4) Docket Text: REDACTED VERSION of [527] Reply Brief by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Jan 4, 2022	569	Redacted Document (Main Document) (9) Docket Text: REDACTED VERSION of [528] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jan 4, 2022	569	Redacted Document (Exhibit A) (1) Docket Text: REDACTED VERSION of [528] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jan 4, 2022	569	Redacted Document (Exhibit B) (5) Docket Text: REDACTED VERSION of [528] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jan 4, 2022	569	Redacted Document (Exhibit C) (7) Docket Text: REDACTED VERSION of [528] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jan 4, 2022	569	Redacted Document (Exhibit D) (18) Docket Text: REDACTED VERSION of [528] Reply Brief, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jan 4, 2022	570	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [560] MEMORANDUM in Support, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A)(Dudash, Amy)
Jan 4, 2022	570	Redacted Document (Exhibit A) (6) Docket Text: REDACTED VERSION of [560] MEMORANDUM in Support, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A)(Dudash, Amy)
Jan 3, 2022	550	Redacted Document (16) Docket Text: REDACTED VERSION of [508] Reply Brief by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	551	Redacted Document (9) Docket Text: REDACTED VERSION of [509] Reply Brief by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	552	Redacted Document (10) Docket Text: REDACTED VERSION of [510] Reply Brief, by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	553	Redacted Document (27) Docket Text: REDACTED VERSION of [512] Reply Brief, by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	554	Redacted Document (23) Docket Text: REDACTED VERSION of [513] Reply Brief, by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	555	Redacted Document (11) Docket Text: REDACTED VERSION of [514] Reply Brief by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	556	Redacted Document (9) Docket Text: REDACTED VERSION of [515] Reply Brief, by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	557	Redacted Document (20) Docket Text: REDACTED VERSION of [516] Reply Brief, by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	558	Redacted Document (14) Docket Text: REDACTED VERSION of [517] Reply Brief by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	559	Redacted Document (11) Docket Text: REDACTED VERSION of [518] Reply Brief, by Genentech, Inc.. (Mayo, Andrew)
Jan 3, 2022	562	Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Genentech, Inc. re [450] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude the Opinions of Baxalta's Expert Witness Dr. Jeffrey J. Gray and Related Opinions of Baxalta's Expert Witness Dr. Wayne A. Marasco), [442] MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra, [446] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 5 to Preclude Baxalta From Presenting Arguments and Evidence Regarding Certain Deposited Hybridomas), [441] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 1 Regarding Literal Infringement), [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit, [451] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Witness Dr. Sriram Krishnaswamy), [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young , [455] MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials, [447] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 6 to Preclude Baxalta From Offering Testimony Regarding scFv Derivatives), [445] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody), [443] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 2 to Preclude Improper Evidence of Willfulness), [448] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxaltas Expert Leonard Paul Freedman), [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III , [444] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 3 to Preclude Named Inventor Dr. Scheiflinger From Offering Expert Opinions), [457] MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness, [453] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Dr. Wayne A. Marasco), [459] MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning , [452] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert James E. Malackowski), [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts, [439] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness, [449] MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense. (Mayo, Andrew)
Dec 27, 2021	529	Redacted Document (10) Docket Text: REDACTED VERSION of [489] Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	530	Redacted Document (9) Docket Text: REDACTED VERSION of [490] Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	531	Redacted Document (6) Docket Text: REDACTED VERSION of [491] Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	532	Redacted Document (6) Docket Text: REDACTED VERSION of [493] Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	533	Redacted Document (8) Docket Text: REDACTED VERSION of [494] Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	534	Redacted Document (6) Docket Text: REDACTED VERSION of [497] Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	535	Redacted Document (18) Docket Text: REDACTED VERSION of [499] Answering Brief in Opposition, by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	536	Redacted Document (9) Docket Text: REDACTED VERSION of [501] Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	537	Redacted Document (14) Docket Text: REDACTED VERSION of [502] Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew)
Dec 27, 2021	538	Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [503] Declaration of Naz Wehrli by Genentech, Inc.. (Attachments: # (1) Exhibit 1-28)(Mayo, Andrew)
Dec 27, 2021	538	Redacted Document (Exhibit 1-28) (30) Docket Text: REDACTED VERSION of [503] Declaration of Naz Wehrli by Genentech, Inc.. (Attachments: # (1) Exhibit 1-28)(Mayo, Andrew)
Dec 27, 2021	539	Redacted Document (Main Document) (10) Docket Text: REDACTED VERSION of [485] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Dudash, Amy)
Dec 27, 2021	539	Redacted Document (Exhibit 1) (5) Docket Text: REDACTED VERSION of [485] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Dudash, Amy)
Dec 27, 2021	539	Redacted Document (Exhibit 2) (7) Docket Text: REDACTED VERSION of [485] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Dudash, Amy)
Dec 27, 2021	539	Redacted Document (Exhibit 3) (13) Docket Text: REDACTED VERSION of [485] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Dudash, Amy)
Dec 27, 2021	539	Redacted Document (Exhibit 4) (7) Docket Text: REDACTED VERSION of [485] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4)(Dudash, Amy)
Dec 27, 2021	540	Redacted Document (Main Document) (8) Docket Text: REDACTED VERSION of [486] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Dudash, Amy)
Dec 27, 2021	540	Redacted Document (Exhibit 1) (30) Docket Text: REDACTED VERSION of [486] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Dudash, Amy)
Dec 27, 2021	540	Redacted Document (Exhibit 2) (13) Docket Text: REDACTED VERSION of [486] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Dudash, Amy)
Dec 27, 2021	540	Redacted Document (Exhibit 3) (3) Docket Text: REDACTED VERSION of [486] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Dudash, Amy)
Dec 27, 2021	540	Redacted Document (Exhibit 4) (9) Docket Text: REDACTED VERSION of [486] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Dudash, Amy)
Dec 27, 2021	540	Redacted Document (Exhibit 5) (3) Docket Text: REDACTED VERSION of [486] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Dudash, Amy)
Dec 27, 2021	541	Redacted Document (6) Docket Text: REDACTED VERSION of [487] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Dec 27, 2021	542	Redacted Document (4) Docket Text: REDACTED VERSION of [488] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Main Document) (14) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 1) (4) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 2) (24) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 3) (4) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 4) (10) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 5) (8) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 6) (7) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 7) (3) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 8) (7) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 9) (6) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	543	Redacted Document (Exhibit 10) (4) Docket Text: REDACTED VERSION of [492] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Dudash, Amy)
Dec 27, 2021	544	Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [495] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	544	Redacted Document (Exhibit 1) (7) Docket Text: REDACTED VERSION of [495] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	544	Redacted Document (Exhibit 2) (6) Docket Text: REDACTED VERSION of [495] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	544	Redacted Document (Exhibit 3) (9) Docket Text: REDACTED VERSION of [495] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	545	Redacted Document (Main Document) (12) Docket Text: REDACTED VERSION of [498] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	545	Redacted Document (Exhibit 1) (10) Docket Text: REDACTED VERSION of [498] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	545	Redacted Document (Exhibit 2) (4) Docket Text: REDACTED VERSION of [498] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	545	Redacted Document (Exhibit 3) (6) Docket Text: REDACTED VERSION of [498] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	546	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [500] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Dec 27, 2021	546	Redacted Document (Exhibit 1) (9) Docket Text: REDACTED VERSION of [500] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Main Document) (9) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 1) (8) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 2) (5) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 3) (6) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 4) (4) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 5) (13) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 6) (4) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 7) (30) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	547	Redacted Document (Exhibit 8) (6) Docket Text: REDACTED VERSION of [504] Answering Brief in Opposition,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8)(Dudash, Amy)
Dec 27, 2021	548	Redacted Document (Main Document) (14) Docket Text: REDACTED VERSION of [505] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Dudash, Amy)
Dec 27, 2021	548	Redacted Document (Exhibit 1) (1) Docket Text: REDACTED VERSION of [505] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Dudash, Amy)
Dec 27, 2021	548	Redacted Document (Exhibit 2) (1) Docket Text: REDACTED VERSION of [505] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Dudash, Amy)
Dec 27, 2021	549	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [506] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	549	Redacted Document (Exhibit 1) (29) Docket Text: REDACTED VERSION of [506] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	549	Redacted Document (Exhibit 2) (6) Docket Text: REDACTED VERSION of [506] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 27, 2021	549	Redacted Document (Exhibit 3) (8) Docket Text: REDACTED VERSION of [506] Answering Brief in Opposition, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dudash, Amy)
Dec 23, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER granting [507] the parties Joint Motion to Postpone Trial. The Pretrial Conference scheduled for January 19, 2022, and the Trial scheduled for January 24, 2022, are hereby postponed. Ordered by Judge Timothy B. Dyk on 12/23/2021. (smg)
Dec 23, 2021	511	Reply Brief (3) Docket Text: REPLY BRIEF re [445] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody) filed by Genentech, Inc.. (Mayo, Andrew)
Dec 23, 2021	521	Reply Brief (4) Docket Text: REPLY BRIEF re [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Dec 23, 2021	525	Reply Brief (4) Docket Text: REPLY BRIEF re [457] MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Dec 16, 2021	496	Answering Brief in Opposition (7) Docket Text: ANSWERING BRIEF in Opposition re [455] MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials filed by Genentech, Inc..Reply Brief due date per Local Rules is 12/27/2021. (Balick, Steven)
Dec 15, 2021	464	Redacted Document (9) Docket Text: REDACTED VERSION of [441] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 1 Regarding Literal Infringement) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	465	Redacted Document (9) Docket Text: REDACTED VERSION of [443] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 2 to Preclude Improper Evidence of Willfulness) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	466	Redacted Document (6) Docket Text: REDACTED VERSION of [444] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 3 to Preclude Named Inventor Dr. Scheiflinger From Offering Expert Opinions) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	467	Redacted Document (7) Docket Text: REDACTED VERSION of [445] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 4 to Preclude Baxalta From Offering Written-Description Testimony that Factor X is an Obvious Choice for a Second Antigen for a Bispecific Antibody) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	468	Redacted Document (11) Docket Text: REDACTED VERSION of [446] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 5 to Preclude Baxalta From Presenting Arguments and Evidence Regarding Certain Deposited Hybridomas) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	469	Redacted Document (7) Docket Text: REDACTED VERSION of [447] MOTION in Limine (Genentech, Inc.'s Motion In Limine No. 6 to Preclude Baxalta From Offering Testimony Regarding scFv Derivatives) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	470	Redacted Document (15) Docket Text: REDACTED VERSION of [448] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxaltas Expert Leonard Paul Freedman) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	471	Redacted Document (12) Docket Text: REDACTED VERSION of [451] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Witness Dr. Sriram Krishnaswamy) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	472	Redacted Document (23) Docket Text: REDACTED VERSION of [452] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert James E. Malackowski) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	473	Redacted Document (12) Docket Text: REDACTED VERSION of [453] MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude Certain Opinions of Baxalta's Expert Dr. Wayne A. Marasco) by Genentech, Inc.. (Mayo, Andrew)
Dec 15, 2021	474	Redacted Document (Main Document) (10) Docket Text: REDACTED VERSION of [454] Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions (Volume I of II) by Genentech, Inc.. (Attachments: # (1) Exhibit 1-37)(Mayo, Andrew)
Dec 15, 2021	474	Redacted Document (Exhibit 1-37) (30) Docket Text: REDACTED VERSION of [454] Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions (Volume I of II) by Genentech, Inc.. (Attachments: # (1) Exhibit 1-37)(Mayo, Andrew)
Dec 15, 2021	475	Redacted Document (Main Document) (10) Docket Text: REDACTED VERSION of [456] Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions (Volume II of II) by Genentech, Inc.. (Attachments: # (1) Exhibit 38-57)(Mayo, Andrew)
Dec 15, 2021	475	Redacted Document (Exhibit 38-57) (30) Docket Text: REDACTED VERSION of [456] Declaration of David E. Cole in Support of Genentech, Inc.'s Motions In Limine and Daubert Motions (Volume II of II) by Genentech, Inc.. (Attachments: # (1) Exhibit 38-57)(Mayo, Andrew)
Dec 15, 2021	476	Redacted Document (Main Document) (10) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 1) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 2) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 3) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 4) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 5) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 6) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 7) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Exhibit 8) (4) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	476	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [438] MOTION in Limine to Exclude Evidence of Post-Priority Development Efforts by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	477	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [439] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	477	Redacted Document (Exhibit 1) (30) Docket Text: REDACTED VERSION of [439] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	477	Redacted Document (Exhibit 2) (30) Docket Text: REDACTED VERSION of [439] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	477	Redacted Document (Exhibit 3) (5) Docket Text: REDACTED VERSION of [439] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	477	Redacted Document (Exhibit 4) (1) Docket Text: REDACTED VERSION of [439] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	477	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [439] MOTION in Limine No. 2 to Exclude John P. Sheehan, M.D. and William R. Strohl Reliance on Confidential Documents for Written Description, Enablement and Indefiniteness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit A) (4) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit B) (4) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit C) (12) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit D) (7) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit E) (14) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit F) (9) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit G) (30) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Exhibit H) (30) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	478	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [440] MOTION in Limine No. 3 to Exclude Certain Evidence of Japanese Proceedings Concerning the Japanese Counterpart of the Patent-in-Suit by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	479	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [442] MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	479	Redacted Document (Exhibit 1) (7) Docket Text: REDACTED VERSION of [442] MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	479	Redacted Document (Exhibit 2) (1) Docket Text: REDACTED VERSION of [442] MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	479	Redacted Document (Exhibit 3) (1) Docket Text: REDACTED VERSION of [442] MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	479	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [442] MOTION in Limine No. 4 to Exclude Any Genentech, Chugai, and Roche Patents Relating to Hemlibra by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	480	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [449] MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	480	Redacted Document (Exhibit 1) (5) Docket Text: REDACTED VERSION of [449] MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	480	Redacted Document (Exhibit 2) (9) Docket Text: REDACTED VERSION of [449] MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	480	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [449] MOTION in Limine No. 5 to Preclude Genentech from Introducing Evidence or Testimony Relating to Antibodies Falling Outside the Scope of the Claims to Support Its Written Description Defense by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	481	Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [457] MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	481	Redacted Document (Exhibit 1) (1) Docket Text: REDACTED VERSION of [457] MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	481	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [457] MOTION in Limine No. 7 to Preclude Genentech from Relying on the Court's Claim Construction Order to Refute Willfulness by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Main Document) (17) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Exhibit 1) (1) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Exhibit 2) (1) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Exhibit 3) (1) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Exhibit 4) (1) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Exhibit 5) (1) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Exhibit 6) (28) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Exhibit 7) (16) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	482	Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [458] MOTION to Exclude Certain Opinions and Testimony of Drs. Steven Schwartz and Guy Young by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	483	Redacted Document (Main Document) (11) Docket Text: REDACTED VERSION of [459] MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	483	Redacted Document (Exhibit 1) (1) Docket Text: REDACTED VERSION of [459] MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	483	Redacted Document (Exhibit 2) (1) Docket Text: REDACTED VERSION of [459] MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	483	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [459] MOTION to Exclude Certain Opinions and Testimony of Dr. Richard Manning by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	484	Redacted Document (Main Document) (10) Docket Text: REDACTED VERSION of [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	484	Redacted Document (Exhibit A) (16) Docket Text: REDACTED VERSION of [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	484	Redacted Document (Exhibit B) (30) Docket Text: REDACTED VERSION of [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	484	Redacted Document (Exhibit C) (22) Docket Text: REDACTED VERSION of [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	484	Redacted Document (Exhibit D) (1) Docket Text: REDACTED VERSION of [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	484	Redacted Document (Exhibit E) (7) Docket Text: REDACTED VERSION of [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Dudash, Amy)
Dec 15, 2021	484	Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [460] MOTION to Exclude Opinions and Testimony of Dr. Dougald M. Monroe, III by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Dudash, Amy)
Dec 13, 2021	463	Stipulation and Order (6) Docket Text: Joint STIPULATION of Fact Regarding Hybridoma Technology and the Number of Anti-Factor IX/IXa Antibodies Disclosed In The '590 Patent. Signed by Judge Timothy Belcher Dyk on 12/13/2021. (nmg)
Dec 9, 2021	462	Redacted Document (30) Docket Text: REDACTED VERSION of [436] MEMORANDUM in Support, by Genentech, Inc.. (Balick, Steven)
Dec 8, 2021	450	Motion to Preclude (12) Docket Text: MOTION to Preclude (Genentech, Inc.'s Daubert Motion to Exclude the Opinions of Baxalta's Expert Witness Dr. Jeffrey J. Gray and Related Opinions of Baxalta's Expert Witness Dr. Wayne A. Marasco) - filed by Genentech, Inc.. (Balick, Steven)
Dec 8, 2021	455	Motion in Limine (Main Document) (6) Docket Text: MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Text of Proposed Order)(Dudash, Amy)
Dec 8, 2021	455	Motion in Limine (Text of Proposed Order) (2) Docket Text: MOTION in Limine No. 6 to Exclude References to Plaintiffs' Motion for a Preliminary Injunction and Certain Related Materials - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Text of Proposed Order)(Dudash, Amy)
Dec 8, 2021	461	Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [433] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Dec 8, 2021	461	Redacted Document (Exhibit 1) (30) Docket Text: REDACTED VERSION of [433] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Dec 8, 2021	461	Redacted Document (Exhibit 2) (3) Docket Text: REDACTED VERSION of [433] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Dec 8, 2021	461	Redacted Document (Exhibit 3) (30) Docket Text: REDACTED VERSION of [433] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Dec 8, 2021	461	Redacted Document (Exhibit 4) (30) Docket Text: REDACTED VERSION of [433] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Dec 8, 2021	461	Redacted Document (Exhibit 5) (1) Docket Text: REDACTED VERSION of [433] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Dec 8, 2021	461	Redacted Document (Exhibit 6) (2) Docket Text: REDACTED VERSION of [433] Proposed Pretrial Order by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Dec 3, 2021	437	Stipulation (6) Docket Text: STIPULATION of Fact Regarding Hybridoma Technology and the Number of Anti-Factor IX/IXa Antibodies Disclosed In The '590 Patent, by Genentech, Inc.. (Balick, Steven)
Dec 2, 2021	435	Motion to Seal (2) Docket Text: MOTION to Seal (Unopposed Renewed and Narrowed Motion to Seal Portions of Summary Judgment Hearing Transcript) - filed by Genentech, Inc.. (Balick, Steven)
Dec 1, 2021	434	Certificate of Service (3) Docket Text: CERTIFICATE OF SERVICE of Proposed Final Pretrial Order and Exhibits 1-6 by Baxalta GmbH, Baxalta Incorporated re [433] Proposed Pretrial Order (Dudash, Amy)
Nov 29, 2021	432	Redacted Document (9) Docket Text: REDACTED VERSION of [430] MEMORANDUM in Support, by Genentech, Inc.. (Mayo, Andrew)
Nov 24, 2021	431	Transcript (213) Docket Text: Official Transcript of Hearing held on 11/19/2021 before Judge Timothy B. Dyk. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/15/2021. Redacted Transcript Deadline set for 12/27/2021. Release of Transcript Restriction set for 2/22/2022. (cna, )
Nov 22, 2021	N/A	Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk. Motion Hearing re [407] Motion for Summary Judgment held on 11/19/2021, at 10:00 AM. As stated on the record, [429] Genentechs Motion to Seal is DENIED. Parties to file stipulation by 12/03/21. (Court reporter was present) (nmg)
Nov 18, 2021	429	Motion to Seal (2) Docket Text: MOTION to Seal Courtroom and Transcript Regarding Summary Judgment Hearing (UNOPPOSED) - filed by Genentech, Inc.. (Balick, Steven)
Oct 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [428] MOTION for Pro Hac Vice Appearance of Attorney William R. Peterson filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 10/29/2021. (myr)
Oct 29, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William R. Peterson for Baxalta GmbH and Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Oct 27, 2021	427	Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 1) (30) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 2) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 3) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 4) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 5) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 6) (14) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 7) (30) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 8) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 9) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 10) (6) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 11) (10) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 12) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 13) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 14) (7) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 15) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 16) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 17) (6) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 18) (2) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 19) (7) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 20) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 21) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 22) (11) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 23) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 24) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 25) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 26) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 27) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	427	Redacted Document (Exhibit 28) (1) Docket Text: REDACTED VERSION of [424] Answering Brief in Opposition,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28)(Dudash, Amy)
Oct 27, 2021	428	Motion for Leave to Appear Pro Hac Vice (Main Document) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William R. Peterson - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Certification by Counsel to be Admitted Pro Hac Vice)(Dudash, Amy)
Oct 27, 2021	428	Motion for Leave to Appear Pro Hac Vice (Certification by Counsel to be Admitted Pro Hac Vice) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William R. Peterson - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Certification by Counsel to be Admitted Pro Hac Vice)(Dudash, Amy)
Oct 22, 2021	426	Redacted Document (26) Docket Text: REDACTED VERSION of [425] Reply Brief by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	416	Redacted Document (30) Docket Text: REDACTED VERSION of [408] Opening Brief in Support by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	417	Redacted Document (30) Docket Text: REDACTED VERSION of [409] Declaration of David E. Cole (Volume 1 of 2) by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	418	Redacted Document (30) Docket Text: REDACTED VERSION of [410] Declaration of David E. Cole (Volume 2 of 2) by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	419	Redacted Document (6) Docket Text: REDACTED VERSION of [411] Declaration of John P. Sheehan, M.D. by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	420	Redacted Document (30) Docket Text: REDACTED VERSION of [412] Declaration of Stephanie A. Smith, D.V.M., M.S. by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	421	Redacted Document (8) Docket Text: REDACTED VERSION of [413] Declaration of William R. Strohl, Ph.D. by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	422	Redacted Document (3) Docket Text: REDACTED VERSION of [414] Declaration of Guy A. Young, M.D. by Genentech, Inc.. (Mayo, Andrew)
Sep 10, 2021	423	Redacted Document (6) Docket Text: REDACTED VERSION of [415] Declaration of Dr. K. Christopher Garcia by Genentech, Inc.. (Mayo, Andrew)
Sep 3, 2021	407	Motion for Summary Judgment (Main Document) (2) Docket Text: MOTION for Summary Judgment - filed by Genentech, Inc.. (Attachments: # (1) Text of Proposed Order)(Balick, Steven)
Sep 3, 2021	407	Motion for Summary Judgment (Text of Proposed Order) (2) Docket Text: MOTION for Summary Judgment - filed by Genentech, Inc.. (Attachments: # (1) Text of Proposed Order)(Balick, Steven)
Aug 25, 2021	406	Stipulation and Order (4) Docket Text: STIPULATION AND ORDER re D.I. [405]. Signed by Judge Timothy Belcher Dyk on 08/25/2021. (smg)
Aug 24, 2021	405	Stipulation (4) Docket Text: STIPULATION Regarding Briefing of Dispositive Motions, by Genentech, Inc.. (Balick, Steven)
Jul 28, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Catherine Nyarady for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jul 27, 2021	404	Order on Motion to Appear Pro Hac Vice (1) Docket Text: ORDER, granting D.I.[403] Motion to Appear Pro Hac Vice Appearance of Attorney Catherine Nyarady. Signed by Judge Timothy Belcher Dyk on 7/27/2021. (myr)
Jul 23, 2021	403	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Catherine Nyarady - filed by Genentech, Inc.. (Balick, Steven)
Jul 13, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Wan-Shon Lo for Baxalta GmbH, and for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jul 12, 2021	401	Motion for Leave to Appear Pro Hac Vice (Main Document) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wan-Shon Lo - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Certification)(Dudash, Amy)
Jul 12, 2021	401	Motion for Leave to Appear Pro Hac Vice (Certification) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wan-Shon Lo - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Certification)(Dudash, Amy)
Jul 12, 2021	402	Order on Motion to Appear Pro Hac Vice (1) Docket Text: ORDER granting [401] MOTION for Pro Hac Vice Appearance of Attorney Wan-Shon Lo. Signed by Judge Timothy Belcher Dyk on 7/12/2021. (nmg)
Apr 5, 2021	400	Order (4) Docket Text: ORDER Approving D.I. [399] Supplementation of Protective Order (Supplementing D.I. [316]). Signed by Judge Timothy Belcher Dyk on 4/5/2021. (kmd)
Apr 2, 2021	399	Stipulation (4) Docket Text: STIPULATION Regarding Supplementation of Protective Order, by Genentech, Inc.. (Balick, Steven)
Mar 11, 2021	396	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Genentech, Inc.'s Second Supplemental Invalidity Contentions; (2) Defendant Genentech, Inc.'s Supplemental Non-Infringement Contentions; and (3) Genentech Inc.'s Supplemental Objections and Responses to Baxalta Incorporated's and Baxalta GmbH's Second Set of Interrogatories (Nos. 21-23, 25 & 27) filed by Genentech, Inc..(Mayo, Andrew)
Mar 11, 2021	397	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to First Set of Interrogatories (Nos. 3, 5, 7, 9-11); Supplemental Responses and Objections to Second Set of Interrogatories (Nos. 12-20, 23-24); Supplemental Responses and Objections to Third Set of Interrogatories (Nos. 25, 27); Second Supplemental Responses and Objections to Second Set of Requests for Admission (Nos. 10, 11, 13); First Supplemental Responses and Objections to Third Set of Requests for Admission (Nos. 24, 31) and Fourth Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Mar 11, 2021	398	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Supplemental Objections and Responses to Baxalta Incorporated's and Baxalta GmbH's First Set of Interrogatories (Nos. 3, 8, 11, 12 & 15-20) filed by Genentech, Inc..(Mayo, Andrew)
Feb 26, 2021	395	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech's Amended and Supplemental Responses and Objections to Baxalta's Rule 30(b)(6) Notice filed by Genentech, Inc..(Mayo, Andrew)
Feb 23, 2021	393	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Genentech's Objections and Responses to Baxalta's Second Set of Requests for Admission (Nos. 4-39); (2) Genentech, Inc.'s Objections and Responses to Baxalta's Fourth Set of Interrogatories (No. 29-30); (3) Genentech, Inc.'s Objections and Responses to Baxalta's Third Set of Interrogatories (No. 28); and (4) Genentech's Objections and Responses to Baxalta's Third Set of Requests for Production (Nos. 117-138) filed by Genentech, Inc..(Mayo, Andrew)
Feb 23, 2021	394	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Feb 22, 2021	391	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Validity Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Feb 22, 2021	392	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Interrogatory No. 1, Fourth Supplemental Objections and Responses to Second Set of Interrogatories (Nos. 7, 9), Fourth Supplemental Objections and Responses to Third Set of Interrogatories (Nos. 21, 22, 23) and Objections and Response to Seventh Set of Requests for Production (No. 118) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Feb 19, 2021	390	Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [386] Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Feb 19, 2021	390	Redacted Document (Exhibit 1) (2) Docket Text: REDACTED VERSION of [386] Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Feb 19, 2021	390	Redacted Document (Exhibit 2) (2) Docket Text: REDACTED VERSION of [386] Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Feb 19, 2021	390	Redacted Document (Exhibit 3) (2) Docket Text: REDACTED VERSION of [386] Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Feb 19, 2021	390	Redacted Document (Exhibit 4) (2) Docket Text: REDACTED VERSION of [386] Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Feb 19, 2021	390	Redacted Document (Exhibit 5) (2) Docket Text: REDACTED VERSION of [386] Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Feb 19, 2021	390	Redacted Document (Exhibit 6) (7) Docket Text: REDACTED VERSION of [386] Letter, to Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Dudash, Amy)
Feb 17, 2021	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - A Telephonic Hearing on the parties' discovery dispute held on February 17, 2021, at 2:00 PM. Baxalta Inc. ordered to supplement its response to Genentech, Inc.'s Interrogatory 9. Remaining relief requested denied without prejudice to the filing of a renewed motion at a later date. (Call lasted for 25 minutes) (Court Report was present) (myr)
Feb 17, 2021	389	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant's Amended Notice of 30(b)(6) Deposition (Topics 1-28) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Feb 12, 2021	387	Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE of Plaintiffs' Letter and Exhibits 1-6 filed under seal [D.I. 386] by Baxalta GmbH, Baxalta Incorporated re [386] Letter, (Dudash, Amy)
Feb 12, 2021	388	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [385] Letter, by Genentech, Inc.. (Attachments: # (1) Exhibit A-J)(Mayo, Andrew)
Feb 12, 2021	388	Redacted Document (Exhibit A-J) (20) Docket Text: REDACTED VERSION of [385] Letter, by Genentech, Inc.. (Attachments: # (1) Exhibit A-J)(Mayo, Andrew)
Feb 5, 2021	384	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Subpoenas filed by Genentech, Inc..(Mayo, Andrew)
Feb 3, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER, On February 2, 2021, the parties notified the court that they are at an impasse regarding various discovery disputes. It is hereby ORDERED that (1) defendants shall file an opening letter brief on or before Friday, February 5, 2021, addressing the disputes; and (2) plaintiffs shall file a responsive letter brief on or before Friday, February 12, 2021, addressing the disputes. The parties' letter briefs shall be no longer than seven pages, double spaced. It is further ORDERED that a telephonic hearing on the discovery disputes is scheduled for Wednesday, February 17, 2021, at 2:00 PM. Counsel for defendants shall initiate the call to chambers once all participants are on the line. Counsel for defendants shall also arrange for a court reporter. Entered by Judge Timothy Belcher Dyk on 2/3/2021. (nmg)
Feb 3, 2021	383	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Genentech, Inc.'s Initial Non-Infringement Contentions and Defendant Genentech, Inc.'s First Supplemental Invalidity Contentions filed by Genentech, Inc..(Mayo, Andrew)
Jan 29, 2021	382	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech Inc.'s Supplemental Objections and Responses to Baxalta Incorporated's and Baxalta GmbH's Interrogatory Nos. 10, 23, and 24 filed by Genentech, Inc..(Mayo, Andrew)
Jan 28, 2021	381	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Response to Second Set of Interrogatories (No. 24), Supplemental Response to First Set of Interrogatories (No. 10-11) and Response to Third Set of Interrogatories (No. 26) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 25, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Olga Berson for Baxalta GmbH and Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Jan 22, 2021	380	SO ORDERED (1) Docket Text: SO ORDERED, re D.I.[375] MOTION for Pro Hac Vice Appearance of Attorney Olga Berson, Ph.D. filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 1/22/2021. (myr)
Jan 21, 2021	378	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Seventh Set of Requests for the Production of Documents and Things (Request No. 118) filed by Genentech, Inc..(Balick, Steven)
Jan 21, 2021	379	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fourth Set of Interrogatories (Nos. 29-30) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 20, 2021	377	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 117-138), Third Set of Interrogatories (No. 28), and Second Set of Requests for Admission Nos. 4-39) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 19, 2021	376	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Suha Patel on February 12, 2021 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 18, 2021	375	Motion for Leave to Appear Pro Hac Vice (Main Document) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Olga Berson, Ph.D. - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Certification of Olga Berson, Ph.D.)(Dudash, Amy)
Jan 18, 2021	375	Motion for Leave to Appear Pro Hac Vice (Certification of Olga Berson, Ph.D.) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Olga Berson, Ph.D. - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Certification of Olga Berson, Ph.D.)(Dudash, Amy)
Jan 14, 2021	371	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Friedrich Dorner on January 28, 2021 filed by Genentech, Inc..(Balick, Steven)
Jan 14, 2021	372	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rebecca Carty on February 10, 2021 filed by Genentech, Inc..(Balick, Steven)
Jan 14, 2021	373	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Friedrich Scheiflinger on February 17, 2021 filed by Genentech, Inc..(Balick, Steven)
Jan 14, 2021	374	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Amended Notice of Rule 30(b)(6) Deposition to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Balick, Steven)
Jan 13, 2021	370	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 7, 2021	369	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech's Sixth Set of Requests for the Production of Documents and Things (Nos. 113-117) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 6, 2021	368	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of David Chaudry on January 27, 2021 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Dec 22, 2020	367	Stipulation and Order (11) Docket Text: STIPULATION AND ORDER Concerning the Protocol for Conducting Remote Depositions. Signed by Judge Timothy Belcher Dyk on 12/22/2020. (amf)
Dec 18, 2020	366	Stipulation (11) Docket Text: Joint STIPULATION and Proposed Order Concerning the Protocol for Conducting Remote Depositions by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Dec 8, 2020	365	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Sixth Set of Requests for the Production of Documents and Things (Request Nos. 113-117) filed by Genentech, Inc..(Balick, Steven)
Dec 7, 2020	364	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' (i) Supplemental Responses and Objections to Genentech Inc.'s Interrogatory Nos. 3, 7, 10 and 11 of Genentech's First Set of Interrogatories, (ii) Supplemental Responses and Objections to Genentech Inc.'s Interrogatory Nos. 15, 16, 19 and 21-24 of Genentech Inc.'s Second Set of Interrogatories, and (iii) First Supplemental Responses and Objections to Genentech Inc.'s Second Set of Requests for Admission (Nos. 14-23) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Dec 4, 2020	N/A	Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - a Telephonic Status Conference held on 10/14/2020, at 2:00 PM (Call lasted for 12 minutes). (Court Reporter was present) (myr)
Nov 30, 2020	363	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Amended Rule 26(a)(1) Initial Disclosures filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Nov 25, 2020	361	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Third Set of Requests for Admission (Nos. 24-42) and Responses and Objections to Third Set of Interrogatories (Nos. 25-27) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Nov 25, 2020	362	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Genentech, Inc.'s Third Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Balick, Steven)
Nov 24, 2020	360	Subpoena Returned Executed (1) Docket Text: SUBPOENA Returned Executed as to Qasim Rizvi on 11/21/2020 (Dudash, Amy)
Nov 20, 2020	359	Subpoena (3) Docket Text: SUBPOENA filed by Baxalta GmbH, Baxalta Incorporated directed to Qasim Rizvi for December 16, 2020 at 9:00 AM Central (Dudash, Amy)
Nov 13, 2020	358	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Second Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Mayo, Andrew)
Nov 11, 2020	357	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Third Set of Requests for Admission (Nos. 24-42) and Genentech, Inc.'s Third Set of Interrogatories (Nos. 25-27) filed by Genentech, Inc..(Mayo, Andrew)
Oct 23, 2020	356	Scheduling Order (6) Docket Text: SCHEDULING ORDER. Signed by Judge Timothy Belcher Dyk on 10/23/2020. (amf)
Oct 21, 2020	355	Proposed Order (8) Docket Text: Joint PROPOSED ORDER Joint Proposed Scheduling Order re [354] Oral Order by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Oct 14, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: As discussed during today's telephonic status conference, the parties shall file an updated proposed scheduling order on or before October 21, 2020. Ordered by Judge Timothy B. Dyk on October 14, 2020. (cna, )
Oct 13, 2020	353	Letter (2) Docket Text: Joint Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Scheduling for Case Going Forward - re [352] Oral Order,,,, Order Setting Teleconference,,,. (Dudash, Amy)
Oct 8, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: On August 27, 2020, the U.S. Court of Appeals for the Federal Circuit issued its decision vacating this court's judgment of noninfringement and remanding the case to this court. Baxalta Inc. v. Genentech, Inc., 972 F.3d 1341, 1349 (Fed. Cir. 2020). The Federal Circuit's mandate issued on October 5, 2020. ECF No. 350. Given the Federal Circuit's decision, a telephonic status conference is scheduled for October 14, 2020, at 2:00 PM. The parties should be prepared to discuss a new scheduling order and related matters. Counsel for plaintiffs shall initiate the call to chambers once all participants are on the line. Counsel shall also arrange for a court reporter. Ordered by Judge Timothy Belcher Dyk on 10/8/2020. (kmd) Modified on 10/8/2020 (kmd).
Oct 5, 2020	350	USCA Mandate (Main Document) (1) Docket Text: MANDATE of USCA as to [339] Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. USCA Decision: Vacated and Remanded. (Attachments: # (1) Opinion, # (2) Judgment)(kmd)
Oct 5, 2020	350	USCA Mandate (Opinion) (15) Docket Text: MANDATE of USCA as to [339] Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. USCA Decision: Vacated and Remanded. (Attachments: # (1) Opinion, # (2) Judgment)(kmd)
Oct 5, 2020	350	USCA Mandate (Judgment) (1) Docket Text: MANDATE of USCA as to [339] Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. USCA Decision: Vacated and Remanded. (Attachments: # (1) Opinion, # (2) Judgment)(kmd)
Oct 5, 2020	351	Notice (Other) (3) Docket Text: NOTICE of of Withdrawal of Certain Pro Hac Vice Counsel by Baxalta GmbH, Baxalta Incorporated (Dudash, Amy)
May 26, 2020	349	Notice (Other) (3) Docket Text: NOTICE of Withdrawal of Appearance of Jesse T. Dyer as counsel for Plaintiffs by Baxalta GmbH, Baxalta Incorporated (Dudash, Amy)
Feb 20, 2020	N/A	Order (0) Docket Text: ORDER Per the request of both parties, the court has transmitted the untranslated copy of the transcript from the deposition of Dr. Randolf Josef Kerschbaumer to counsel for Genentech. Signed by Judge Timothy Belcher Dyk on 2/20/2020. (lam)
Feb 11, 2020	N/A	Order (0) Docket Text: ORDER The court has received an untranslated copy of the transcript from the deposition of Dr. Randolf Josef Kerschbaumer. The parties should advise as to how they would like to proceed. Signed by Judge Timothy Belcher Dyk on 2/11/2020. (lam)
Nov 6, 2019	348	Order on Motion for Miscellaneous Relief (1) Docket Text: ORDER granting [347] MOTION (Genentech's Unopposed Motion for Issuance of a Letter Request to the Austrian District Court for Permission to Use a Stenographer During the Austrian Hearing to Take the Testimony of Named Inventor Dr. Randolf Josef Kerschbaumer). The requested letter in revised form is available for pickup. Signed by Judge Timothy Belcher Dyk on 11/6/19. (lam)
Nov 4, 2019	347	Motion for Miscellaneous Relief (Main Document) (5) Docket Text: MOTION (Genentech's Unopposed Motion for Issuance of a Letter Request to the Austrian District Court for Permission to Use a Stenographer During the Austrian Hearing to Take the Testimony of Named Inventor Dr. Randolf Josef Kerschbaumer) - filed by Genentech, Inc.. (Attachments: # (1) Exhibit A, # (2) Text of Proposed Order)(Balick, Steven)
Nov 4, 2019	347	Motion for Miscellaneous Relief (Exhibit A) (2) Docket Text: MOTION (Genentech's Unopposed Motion for Issuance of a Letter Request to the Austrian District Court for Permission to Use a Stenographer During the Austrian Hearing to Take the Testimony of Named Inventor Dr. Randolf Josef Kerschbaumer) - filed by Genentech, Inc.. (Attachments: # (1) Exhibit A, # (2) Text of Proposed Order)(Balick, Steven)
Nov 4, 2019	347	Motion for Miscellaneous Relief (Text of Proposed Order) (1) Docket Text: MOTION (Genentech's Unopposed Motion for Issuance of a Letter Request to the Austrian District Court for Permission to Use a Stenographer During the Austrian Hearing to Take the Testimony of Named Inventor Dr. Randolf Josef Kerschbaumer) - filed by Genentech, Inc.. (Attachments: # (1) Exhibit A, # (2) Text of Proposed Order)(Balick, Steven)
Sep 10, 2019	346	Order on Motion for Miscellaneous Relief (2) Docket Text: ORDER granting [343] MOTION (Genentech's Unopposed Motion to Perpetuate the Testimony of Austrian Citizen and Named Inventor Dr. Randolf Josef Kerschbaumer). Signed by Judge Timothy Belcher Dyk on 9/10/2019. (lam)
Sep 3, 2019	343	Motion for Miscellaneous Relief (Main Document) (3) Docket Text: MOTION (Genentech's Unopposed Motion to Perpetuate the Testimony of Austrian Citizen and Named Inventor Dr. Randolf Josef Kerschbaumer) - filed by Genentech, Inc.. (Attachments: # (1) Text of Proposed Order)(Balick, Steven)
Sep 3, 2019	343	Motion for Miscellaneous Relief (Text of Proposed Order) (2) Docket Text: MOTION (Genentech's Unopposed Motion to Perpetuate the Testimony of Austrian Citizen and Named Inventor Dr. Randolf Josef Kerschbaumer) - filed by Genentech, Inc.. (Attachments: # (1) Text of Proposed Order)(Balick, Steven)
Sep 3, 2019	345	Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [344] MEMORANDUM in Support, by Genentech, Inc.. (Attachments: # (1) Exhibit A-C)(Balick, Steven)
Sep 3, 2019	345	Redacted Document (Exhibit A-C) (14) Docket Text: REDACTED VERSION of [344] MEMORANDUM in Support, by Genentech, Inc.. (Attachments: # (1) Exhibit A-C)(Balick, Steven)
Feb 20, 2019	342	Appeal Transcript Request (1) Docket Text: TRANSCRIPT REQUEST by Baxalta GmbH, Baxalta Incorporated for proceedings held on June 12, 2018, June 13, 2018, June 14, 2018, September 18, 2018, and October 16, 2018 before Judge Timothy Belcher Dyk, (Dudash, Amy)
Feb 13, 2019	N/A	Oral Order (0) Docket Text: ORAL ORDER re [317] Order Setting Mediation Conferences: The mediation scheduled for 4/10/19 and the mediation submission due date of 3/25/19 are cancelled. Ordered by Judge Mary Pat Thynge on 2/13/19. (cak)
Feb 12, 2019	340	USCA Notice of Docketing ROA (1) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [339] Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. USCA Case Number 19-1527. Entry of Appearance due 02/26/2019. Certificate of Interest is due on 02/26/2019. Docketing Statement due 02/26/2019. Appellants' brief is due 04/15/2019. (bkb)
Feb 8, 2019	339	Notice of Appeal* (1)
Feb 8, 2019	N/A	APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [339] Notice of Appeal (Federal Circuit) filed by Baxalta GmbH, Baxalta Incorporated. ( Filing fee $505, receipt number 0311-2565602.) (Dudash, Amy)
Feb 8, 2019	N/A	Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [339] Notice of Appeal (Federal Circuit). (ddp)
Feb 8, 2019	339	Notice of Appeal (Federal Circuit) (3) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [330] Memorandum and Order, [337] Judgment, . Appeal filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Feb 1, 2019	337	Judgment (4) Docket Text: FINAL JUDGMENT is entered in favor of Genentech, Inc. and against Baxalta Incorporated on all claims asserted in the operative complaint. Genetech's counterclaims for declaratory judgment of non-infringement and a declaratory judgment of invalidity are dismissed without prejudice (see Order for further details) (CASE CLOSED). Signed by Judge Timothy Belcher Dyk on 1/31/2019. (ceg)
Feb 1, 2019	338	Patent/Trademark Report to Commissioner (Main Document) (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,033,590. (Attachments: # (1) Approved Final Judgment)(ceg)
Feb 1, 2019	338	Patent/Trademark Report to Commissioner (Approved Final Judgment) (4) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,033,590. (Attachments: # (1) Approved Final Judgment)(ceg)
Jan 31, 2019	335	Stipulation (4) Docket Text: STIPULATION AND FINAL JUDGMENT by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 31, 2019	336	Disclosure Statement (3) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Takeda Pharmaceutical Company Limited for Baxalta GmbH, Baxalta Incorporated filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 25, 2019	334	Stipulation (4) Docket Text: STIPULATION AND FINAL JUDGMENT, by Genentech, Inc.. (Balick, Steven)
Dec 17, 2018	333	Order (4) Docket Text: Stipulation and Order to Amend the Schedule: ( Fact Discovery completed by 2/8/2019, Opening Expert Reports due by 3/15/2019, Rebuttal Expert Reports due by 4/12/2019, Expert Discovery due by 6/14/2019.) (See Order for Additional Deadlines). Signed by Judge Timothy Belcher Dyk on 12/17/2018. (nmg)
Dec 14, 2018	332	Stipulation (4) Docket Text: STIPULATION Seeking to Amend Case Schedule, by Genentech, Inc.. (Balick, Steven)
Dec 12, 2018	331	Stipulation (4) Docket Text: STIPULATION Seeking to Amend Case Schedule, by Genentech, Inc.. (Balick, Steven)
Dec 3, 2018	330	Memorandum and Order (31) Docket Text: OPINION AND ORDER. Signed by Judge Timothy Belcher Dyk on 12/3/2018. (nmg)
Nov 30, 2018	329	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses and Objections to Genentech, Inc.'s Interrogatory No. 11 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Nov 27, 2018	327	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses and Objections to Genetech, Inc.'s Second Set of Requests for Admission (Nos. 10-13) filed by Baxalta Incorporated.(Dudash, Amy)
Nov 27, 2018	328	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Response and Objections to Genentech, Inc.'s interrogatory No. 4 filed by Baxalta Incorporated.(Dudash, Amy)
Nov 8, 2018	326	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Letter Rogatory to Compel the Testimony of Dr. Randolf Kerschbaumer, filed by Genentech, Inc..(Balick, Steven)
Nov 7, 2018	325	Scheduling Order (3) Docket Text: ORDER Amending Schedule: Fact Discovery completed by 12/14/2018. Opening Expert Reports due by 1/18/2019. Rebuttal Expert Reports due by 2/15/2019. Reply Expert Reports due by 3/8/2019. Expert Discovery due by 4/19/2019. Motions for Summary Judgment due by 5/3/2019. Responses to Motions for Summary Judgment due by 5/17/2019. Reply to Motions for Summary Judgment due by 5/24/2019. Signed by Judge Timothy Belcher Dyk on 11/7/2018. (nmg)
Nov 5, 2018	321	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gallia Levy on November 13, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Nov 5, 2018	322	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gina Chapman on November 15, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Nov 5, 2018	323	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kate Skrable on November 16, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Nov 5, 2018	324	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Qasim Rizvi on December 4, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Nov 2, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: The telephonic status conference scheduled for November 2, 2018 at 11AM is canceled. Ordered by Judge Timothy B. Dyk on 11/2/2018. (crb)
Nov 2, 2018	320	Transcript (298) Docket Text: Official Transcript of Markman Hearing held on 10/16/2018 before Judge Timothy Dyk. Court Reporter/Transcriber Ronda J. Thomas,Telephone number 312-386-2000. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 11/23/2018. Redacted Transcript Deadline set for 12/3/2018. Release of Transcript Restriction set for 1/31/2019. (crb)
Nov 1, 2018	319	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Genentech, Inc.'s Interrogatory Nos. 4 and 7 and Plaintiffs' Supplemental Responses and Objections to Genentech's Interrogatory Nos. 15, 16, and 21-23 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Oct 30, 2018	317	Order Setting Mediation Conferences (7) Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 4/10/2019 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/30/18. (cak)
Oct 30, 2018	318	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Supplemental Objections and Responses to Baxalta's First Set of Interrogatories (Nos. 120) filed by Genentech, Inc..(Mayo, Andrew)
Oct 29, 2018	316	Order (29) Docket Text: ORDER Approving D.I. [314] Stipulated Protective Order filed by Genentech, Inc. Signed by Judge Timothy Belcher Dyk on 10/26/2018. (nmg)
Oct 26, 2018	315	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [310] Letter, Response to Genentech's Letter Motion to Compel by Baxalta GmbH. (Attachments: # (1) Exhibit A-D [REDACTED])(Dudash, Amy)
Oct 26, 2018	315	Redacted Document (Exhibit A-D [REDACTED]) (4) Docket Text: REDACTED VERSION of [310] Letter, Response to Genentech's Letter Motion to Compel by Baxalta GmbH. (Attachments: # (1) Exhibit A-D [REDACTED])(Dudash, Amy)
Oct 24, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: The parties are directed to attempt to resolve the discovery disputes reflected in their letters dated October 12, 2018 (ECF No. [308]), and October 19, 2018 (ECF No. [310]). The parties are to present any unresolved disputes at a telephonic status conference on November 2, 2018 at 11:00 a.m. Ordered by Judge Timothy B. Dyk on 10/24/2018. (*a status conference is set for 11/2/2018 at 11:00 a.m.) (ceg)
Oct 23, 2018	312	Letter (1) Docket Text: Letter to Honorable Judge Timothy B. Dyk from Amy M. Dudash regarding regarding Case Schedule. (Dudash, Amy)
Oct 23, 2018	313	Proposed Order (3) Docket Text: PROPOSED ORDER to Amend the Schedule [STIPULATED] by Baxalta Incorporated. (Dudash, Amy)
Oct 23, 2018	314	Proposed Order (29) Docket Text: PROPOSED ORDER (Stipulated Protective Order), by Genentech, Inc.. (Balick, Steven)
Oct 19, 2018	311	Exhibit to a Document (Main Document) (4) Docket Text: EXHIBIT re [310] Letter, [Exhibits E-H] by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit Exhibit F, # (2) Exhibit Exhibit G, # (3) Exhibit H)(Dudash, Amy)
Oct 19, 2018	311	Exhibit to a Document (Exhibit Exhibit F) (4) Docket Text: EXHIBIT re [310] Letter, [Exhibits E-H] by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit Exhibit F, # (2) Exhibit Exhibit G, # (3) Exhibit H)(Dudash, Amy)
Oct 19, 2018	311	Exhibit to a Document (Exhibit Exhibit G) (4) Docket Text: EXHIBIT re [310] Letter, [Exhibits E-H] by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit Exhibit F, # (2) Exhibit Exhibit G, # (3) Exhibit H)(Dudash, Amy)
Oct 19, 2018	311	Exhibit to a Document (Exhibit H) (15) Docket Text: EXHIBIT re [310] Letter, [Exhibits E-H] by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit Exhibit F, # (2) Exhibit Exhibit G, # (3) Exhibit H)(Dudash, Amy)
Oct 16, 2018	N/A	Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Markman Hearing held on 10/16/2018. As stated on the record, Genentech's motion to compel discovery of Baxalta's 2015 collaboration agreement with Novimmune S.A. to research and develop bispecific antibodies for the treatment of hemophilia A using Novimmune's bispecific-antibody technology, and Baxalta's 2017 license agreement with Novimmune to develop and commercialize those bispecific antibodies is GRANTED, but is DENIED without prejudice as to experimental data and the royalty rates and compensation paid to Novimmune. (Court Reporter: Ronda Thomas of Epiq Court Reporting). (ceg)
Oct 15, 2018	309	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Genentech, Inc.'s Interrogatory No. 11 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Oct 12, 2018	307	Motion for Issuance of Letters Rogatory (Main Document) (3) Docket Text: MOTION for Issuance of Letters Rogatory Requiring the Testimony of Named Inventor Dr. Randolf Kerschbaumer (Unopposed) - filed by Genentech, Inc.. (Attachments: # (1) Exhibit 1 & 2)(Mayo, Andrew)
Oct 12, 2018	307	Motion for Issuance of Letters Rogatory (Exhibit 1 & 2) (30) Docket Text: MOTION for Issuance of Letters Rogatory Requiring the Testimony of Named Inventor Dr. Randolf Kerschbaumer (Unopposed) - filed by Genentech, Inc.. (Attachments: # (1) Exhibit 1 & 2)(Mayo, Andrew)
Oct 12, 2018	308	Letter (Main Document) (6) Docket Text: Letter to The Honorable Timothy B. Dyk from Andrew C. Mayo regarding request that the Court: 1) deem Baxalta to have admitted certain Requests for Admission; and 2) compel Baxalta to respond to certain Interrogatories and Document Requests. (Attachments: # (1) Exhibit 1-12)(Mayo, Andrew)
Oct 12, 2018	308	Letter (Exhibit 1-12) (30) Docket Text: Letter to The Honorable Timothy B. Dyk from Andrew C. Mayo regarding request that the Court: 1) deem Baxalta to have admitted certain Requests for Admission; and 2) compel Baxalta to respond to certain Interrogatories and Document Requests. (Attachments: # (1) Exhibit 1-12)(Mayo, Andrew)
Oct 8, 2018	306	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Objections and Responses to Baxalta's Second Set of Interrogatories (Nos. 21-27) filed by Genentech, Inc..(Mayo, Andrew)
Oct 4, 2018	304	Letter (1) Docket Text: Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding the Parties' Proposed Amendments to the Case Schedule (D.I. 174). (Balick, Steven)
Oct 4, 2018	305	Stipulation (3) Docket Text: STIPULATION Regarding the Parties' Proposed Amendments to the Case Schedule (D.I. 174), by Genentech, Inc.. (Balick, Steven)
Oct 1, 2018	302	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Responses and Objections to Genentech, Inc.'s Second Set of Interrogatories filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Oct 1, 2018	303	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Supplemental Objections and Responses to Baxalta's Interrogatory No. 13 filed by Genentech, Inc..(Mayo, Andrew)
Sep 26, 2018	300	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Michael Moye on October 3, 2018 filed by Genentech, Inc..(Mayo, Andrew)
Sep 26, 2018	301	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Cristin Hubbard on October 2, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Sep 25, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing previously scheduled for September 21, 2018, is now rescheduled for October 16, 2018, at 10:00 a.m. in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. Ordered by Judge Timothy B. Dyk on 9/25/18. (ceg)
Sep 24, 2018	297	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech's Objections and Responses to Baxalta's Second Set of Requests for Production filed by Genentech, Inc..(Mayo, Andrew)
Sep 24, 2018	298	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Gabi Gerstenbauer on September 28, 2018 filed by Genentech, Inc..(Mayo, Andrew)
Sep 24, 2018	299	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH Responses and Objections to Genetech, Inc.'s Fifth Set of Requests for the Production of Documents and Things filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Sep 21, 2018	296	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech, Inc.'s Second Set of Interrogatories (Nos. 12-24) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Sep 20, 2018	294	Transcript (21) Docket Text: Official Transcript of the Status Teleconference held on 9/18/2018 before Judge Timothy B. Dyk. Court Reporter Carol Connolly. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/11/2018. Redacted Transcript Deadline set for 10/22/2018. Release of Transcript Restriction set for 12/19/2018. (nmg)
Sep 20, 2018	295	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech, Inc.'s Second Set of Requests for Admission (Nos. 9-23) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Sep 19, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing scheduled for 9/21/2018 is cancelled and will be rescheduled for a later date. Ordered by Judge Timothy Belcher Dyk on 9/19/2018. (ceg)
Sep 19, 2018	292	Proposed Order (5) Docket Text: Amended PROPOSED ORDER Dismissing Defendant Chugai Pharmaceutical Co., Ltd. and Stipulation by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Sep 19, 2018	293	SO ORDERED (2) Docket Text: SO ORDERED, [292] First Amended Stipulation and Order Dismissing Defendant Chugai Pharmaceutical Co., Ltd. Signed by Judge Timothy Belcher Dyk on 9/19/2018. (ceg)
Sep 18, 2018	N/A	Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Status Conference held on 9/18/2018. (ceg)
Sep 13, 2018	291	Proposed Order (5) Docket Text: PROPOSED ORDER Dismissing Defendant Chugai Pharmaceutical Co., Ltd. [Stipulated] by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Sep 12, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: The Markman Hearing set for September 13, 2018, is rescheduled for September 21, 2018, at 11:00AM in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. Ordered by Judge Timothy B. Dyk on 9/12/18. (nmg)
Sep 7, 2018	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of counsel, the pdf of D.I. [282] has been replaced and the docket text corrected to reflect that this is the "Fifth" Set of Requests for the Production of Documents. (nmf)
Sep 7, 2018	289	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech's Fourth Set of Requests for Production of Documents and Things (No. 108) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Sep 7, 2018	290	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Notice of Deposition (Topics 1-45) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Sep 5, 2018	287	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories (Nos. 21-27) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Sep 5, 2018	288	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Notices of Deposition Directed to Nancy Valente, Kate Skrable, Glenn Pierce, Bea Lavery, Gina Chapman, and Gallia Levy filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Aug 29, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: The parties should be prepared to argue the discovery dispute raised in parties letters dated August 15, 2018, ECF No. [276], and August 22, 2018, ECF No. [280], at the Markman hearing scheduled for Thursday, September 13, 2018, at 10:00AM in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. Ordered by Judge Timothy B. Dyk on 8/19/18. (crb)
Aug 29, 2018	286	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [280] Letter by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A)(Dudash, Amy)
Aug 29, 2018	286	Redacted Document (Exhibit A) (1) Docket Text: REDACTED VERSION of [280] Letter by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A)(Dudash, Amy)
Aug 27, 2018	285	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Genentech, Inc.'s First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Mayo, Andrew)
Aug 24, 2018	284	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 108-117) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Aug 23, 2018	281	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Qasim Rizvi and Notice of Deposition of Cristin Hubbard filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Aug 23, 2018	282	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Fifth Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc.(Mayo, Andrew) Modified on 9/7/2018 (nmf). (Main Document 282 replaced on 9/7/2018) (nmf, ).
Aug 23, 2018	283	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [276] Letter by Genentech, Inc.. (Attachments: # (1) Exhibit 1-10)(Mayo, Andrew)
Aug 23, 2018	283	Redacted Document (Exhibit 1-10) (30) Docket Text: REDACTED VERSION of [276] Letter by Genentech, Inc.. (Attachments: # (1) Exhibit 1-10)(Mayo, Andrew)
Aug 21, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Marissa C.M. Doran for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 21, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander F. Atkins for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 21, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Josephine Young for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 21, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Naz Wehrli for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 21, 2018	279	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Second Set of Interrogatories (Nos. 12-24) and Genentech, Inc.'s Second Set of Requests for Admission to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Mayo, Andrew)
Aug 20, 2018	278	Order on Motion to Appear Pro Hac Vice (1) Docket Text: ORDER granting [274] MOTION for Pro Hac Vice Appearance of Attorney Josephine Young, Naz Wehrli, Marissa C.M. Doran, and Alexander F. Atkins. Signed by Judge Timothy Belcher Dyk on 8/17/2018. (crb)
Aug 17, 2018	277	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Genentech's Third Requests for Production of Documents and Things re [238] Notice of Service filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Aug 10, 2018	275	Order (1) Docket Text: ORDER, The documents listed in Exhibit A to the parties' joint letter, ECF No. 254-1, are ADMITTED and are part of the preliminary injunction record. The parties' objections to inclusion of these documents are OVERRULED. Signed by Judge Timothy Belcher Dyk on 8/10/2018. (crb)
Aug 9, 2018	274	Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Josephine Young, Naz Wehrli, Marissa C.M. Doran, and Alexander F. Atkins - filed by Genentech, Inc.. (Balick, Steven)
Aug 8, 2018	264	Redacted Document (3) Docket Text: REDACTED VERSION of [258] Letter by Genentech, Inc.. (Balick, Steven)
Aug 8, 2018	265	Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [259] Declaration, (Declaration of Gina Chapman) by Genentech, Inc.. (Attachments: # (1) Exhibit A-B)(Balick, Steven)
Aug 8, 2018	265	Redacted Document (Exhibit A-B) (12) Docket Text: REDACTED VERSION of [259] Declaration, (Declaration of Gina Chapman) by Genentech, Inc.. (Attachments: # (1) Exhibit A-B)(Balick, Steven)
Aug 8, 2018	266	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Friedrich Scheiflinger filed by Genentech, Inc..(Balick, Steven)
Aug 8, 2018	267	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Randolf Kerschbaumer filed by Genentech, Inc..(Balick, Steven)
Aug 8, 2018	268	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Thomas Larmondra filed by Genentech, Inc..(Balick, Steven)
Aug 8, 2018	269	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Noah Brown filed by Genentech, Inc..(Balick, Steven)
Aug 8, 2018	270	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Michael Moye filed by Genentech, Inc..(Balick, Steven)
Aug 8, 2018	271	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Gabi Gerstenbauer filed by Genentech, Inc..(Balick, Steven)
Aug 8, 2018	272	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Michael Dockal filed by Genentech, Inc..(Balick, Steven)
Aug 8, 2018	273	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Genentech's Notice of Deposition of Baxalta Pursuant to Fed. R. Civ. P. 30(b)(6); (2) Genentech's Responses and Objections to Baxalta's 30(b)(6) Notice; and (3) Genentech, Inc.'s Fourth Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Balick, Steven)
Aug 7, 2018	262	Opinion (29) Docket Text: OPINION & ORDER denying [41] MOTION for Preliminary Injunction Signed by Judge Timothy Belcher Dyk on 8/7/2018. (nmf)
Aug 7, 2018	263	Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Appearance of Colm F. Connolly by Baxalta GmbH, Baxalta Incorporated (Barillare, Jody)
Aug 6, 2018	260	Answer to Counterclaim (26) Docket Text: ANSWER to [240] Answer to Amended Complaint, Counterclaim [Plaintiffs' Answer to the Counterclaims of Defendant Genentech, Inc.] by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Aug 3, 2018	261	Order (3) Docket Text: Corrected ORDER and Commission for Depositions to be Taken in Japan. Signed by Judge Timothy Belcher Dyk on 8/3/2018. (nmg)
Aug 1, 2018	257	Proposed Order (3) Docket Text: Amended PROPOSED ORDER and Commission for Depositions to be Taken in Japan by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jul 30, 2018	255	Order (2) Docket Text: ORDER re [251] Letter to The Honorable Timothy B. Dyk from Amy Dudash regarding the Confidential Preliminary Injunction Hearing Exhibits. (SEE ORDER FOR FURTHER DETAILS). Signed by Judge Timothy Belcher Dyk on 7/26/2018. (crb)
Jul 30, 2018	256	Order (3) Docket Text: ORDER and Commission for Depositions to be Taken in Japan. Signed by Judge Timothy Belcher Dyk on 7/25/2018. (crb)
Jul 27, 2018	254	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove James V. Razick as co-counsel.. (Balick, Steven)
Jul 25, 2018	252	Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [245] Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - Joint Exhibit List, # (2) Exhibit Vol. 1 REDACTED, # (3) Exhibit Vol. 2 REDACTED, # (4) Exhibit Vol. 3 REDACTED, # (5) Exhibit Vol. 4 REDACTED, # (6) Exhibit Vol. 5 REDACTED)(Dudash, Amy)
Jul 25, 2018	252	Redacted Document (Exhibit A - Joint Exhibit List) (30) Docket Text: REDACTED VERSION of [245] Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - Joint Exhibit List, # (2) Exhibit Vol. 1 REDACTED, # (3) Exhibit Vol. 2 REDACTED, # (4) Exhibit Vol. 3 REDACTED, # (5) Exhibit Vol. 4 REDACTED, # (6) Exhibit Vol. 5 REDACTED)(Dudash, Amy)
Jul 25, 2018	252	Redacted Document (Exhibit Vol. 1 REDACTED) (18) Docket Text: REDACTED VERSION of [245] Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - Joint Exhibit List, # (2) Exhibit Vol. 1 REDACTED, # (3) Exhibit Vol. 2 REDACTED, # (4) Exhibit Vol. 3 REDACTED, # (5) Exhibit Vol. 4 REDACTED, # (6) Exhibit Vol. 5 REDACTED)(Dudash, Amy)
Jul 25, 2018	252	Redacted Document (Exhibit Vol. 2 REDACTED) (1) Docket Text: REDACTED VERSION of [245] Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - Joint Exhibit List, # (2) Exhibit Vol. 1 REDACTED, # (3) Exhibit Vol. 2 REDACTED, # (4) Exhibit Vol. 3 REDACTED, # (5) Exhibit Vol. 4 REDACTED, # (6) Exhibit Vol. 5 REDACTED)(Dudash, Amy)
Jul 25, 2018	252	Redacted Document (Exhibit Vol. 3 REDACTED) (30) Docket Text: REDACTED VERSION of [245] Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - Joint Exhibit List, # (2) Exhibit Vol. 1 REDACTED, # (3) Exhibit Vol. 2 REDACTED, # (4) Exhibit Vol. 3 REDACTED, # (5) Exhibit Vol. 4 REDACTED, # (6) Exhibit Vol. 5 REDACTED)(Dudash, Amy)
Jul 25, 2018	252	Redacted Document (Exhibit Vol. 4 REDACTED) (30) Docket Text: REDACTED VERSION of [245] Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - Joint Exhibit List, # (2) Exhibit Vol. 1 REDACTED, # (3) Exhibit Vol. 2 REDACTED, # (4) Exhibit Vol. 3 REDACTED, # (5) Exhibit Vol. 4 REDACTED, # (6) Exhibit Vol. 5 REDACTED)(Dudash, Amy)
Jul 25, 2018	252	Redacted Document (Exhibit Vol. 5 REDACTED) (30) Docket Text: REDACTED VERSION of [245] Letter, regarding Preliminary Injunction Exhibits by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - Joint Exhibit List, # (2) Exhibit Vol. 1 REDACTED, # (3) Exhibit Vol. 2 REDACTED, # (4) Exhibit Vol. 3 REDACTED, # (5) Exhibit Vol. 4 REDACTED, # (6) Exhibit Vol. 5 REDACTED)(Dudash, Amy)
Jul 25, 2018	253	Redacted Document (16) Docket Text: REDACTED VERSION of [242] Statement [Response to Genentech's Post-Hearing Proposed Findings of Fact and Conclusions of Law] by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jul 23, 2018	247	Letter (Main Document) (4) Docket Text: Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding Genentech's Response to Baxalta's Objections to Preliminary Injunction Exhibits - re [245] Letter,. (Attachments: # (1) Exhibit A-D)(Balick, Steven)
Jul 23, 2018	247	Letter (Exhibit A-D) (21) Docket Text: Letter to The Honorable Timothy B. Dyk from Steven J. Balick regarding Genentech's Response to Baxalta's Objections to Preliminary Injunction Exhibits - re [245] Letter,. (Attachments: # (1) Exhibit A-D)(Balick, Steven)
Jul 23, 2018	248	Order Setting Mediation Conferences (1) Docket Text: ORDER Setting Follow-up Teleconference: Plaintiffs' Counsel to initiate the call. A Telephone Conference is set for 10/9/2018 at 10:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR.Signed by Judge Mary Pat Thynge on 7/23/2018. (fms)
Jul 23, 2018	249	Redacted Document (13) Docket Text: REDACTED VERSION of [235] Claim Construction Answering Brief by Genentech, Inc.. (Mayo, Andrew)
Jul 23, 2018	250	Proposed Order (3) Docket Text: PROPOSED ORDER and Commission for Depositions to be Taken in Japan by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jul 23, 2018	251	Letter (Main Document) (1) Docket Text: Letter to The Honorable Timothy B. Dyk from Amy Dudash regarding the Confidential Preliminary Injunction Hearing Exhibits. (Attachments: # (1) Exhibit B)(Dudash, Amy)
Jul 23, 2018	251	Letter (Exhibit B) (16) Docket Text: Letter to The Honorable Timothy B. Dyk from Amy Dudash regarding the Confidential Preliminary Injunction Hearing Exhibits. (Attachments: # (1) Exhibit B)(Dudash, Amy)
Jul 18, 2018	239	Amended Complaint* (1)
Jul 18, 2018	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The answer which was previously docketed as a statement has been deleted and re-docketed as an answer to the amended complaint with counterclaim and jury demand now that the amended complaint has been filed. (SEE D.I. [240]) (nmf)
Jul 18, 2018	239	Amended Complaint (14) Docket Text: First AMENDED COMPLAINT for Patent Infringement and Declaratory Judgment of Patent Infringement against Chugai Pharmaceutical Co., Ltd., Genentech, Inc.- filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jul 18, 2018	240	Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [239] Amended Complaint with Jury Demand, COUNTERCLAIM against Baxalta GmbH, Baxalta Incorporated by Genentech, Inc.(nmf)
Jul 18, 2018	241	Redacted Document (30) Docket Text: REDACTED VERSION of [230] Proposed Findings of Fact by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jul 18, 2018	243	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Baxalta's Sealed Response to Genentech's Findings of Fact and Conclusions of Law by Baxalta GmbH, Baxalta Incorporated re [242] Statement (Dudash, Amy)
Jul 18, 2018	244	Statement (15) Docket Text: STATEMENT [Defendant Genentech's Reply to Baxalta's Proposed Findings of Fact and Conclusions of Law (D.I. 230)] by Genentech, Inc.. (Mayo, Andrew)
Jul 18, 2018	246	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Letter to The Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated re [245] Letter, (Dudash, Amy)
Jul 17, 2018	237	Joinder (2) Docket Text: JOINDER by Chugai Pharmaceutical Co., Ltd., joining in [235] Claim Construction Answering Brief . (Keller, Karen)
Jul 17, 2018	238	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Third Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Mayo, Andrew)
Jul 16, 2018	233	Declaration (Main Document) (2) Docket Text: DECLARATION of David E. Cole in Support of Genentech's Responsive Claim Construction Brief Regarding Remaining Claim Terms, by Genentech, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Balick, Steven)
Jul 16, 2018	233	Declaration (Exhibit 1) (10) Docket Text: DECLARATION of David E. Cole in Support of Genentech's Responsive Claim Construction Brief Regarding Remaining Claim Terms, by Genentech, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Balick, Steven)
Jul 16, 2018	233	Declaration (Exhibit 2) (30) Docket Text: DECLARATION of David E. Cole in Support of Genentech's Responsive Claim Construction Brief Regarding Remaining Claim Terms, by Genentech, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Balick, Steven)
Jul 16, 2018	234	Claim Construction Answering Brief (Main Document) (21) Docket Text: CLAIM CONSTRUCTION ANSWERING BRIEF re [160] Claim Construction Opening Brief filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Exhibit 1)(Dudash, Amy)
Jul 16, 2018	234	Claim Construction Answering Brief (Affidavit of Amy Dudash) (2) Docket Text: CLAIM CONSTRUCTION ANSWERING BRIEF re [160] Claim Construction Opening Brief filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Exhibit 1)(Dudash, Amy)
Jul 16, 2018	234	Claim Construction Answering Brief (Exhibit 1) (4) Docket Text: CLAIM CONSTRUCTION ANSWERING BRIEF re [160] Claim Construction Opening Brief filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Exhibit 1)(Dudash, Amy)
Jul 11, 2018	231	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Sealed Findings of Fact and Conclusions of Law by Baxalta GmbH, Baxalta Incorporated re [230] Proposed Findings of Fact (Dudash, Amy)
Jul 11, 2018	232	Proposed Findings of Fact (30) Docket Text: Proposed Findings of Fact by Genentech, Inc.. (Balick, Steven)
Jul 10, 2018	229	Transcript (122) Docket Text: Official Transcript of Oral Argument held on 7/2/2018 before Judge Timothy B. Dyk. Court Reporter/Transcriber Kenneth Norris,Telephone number 1-800-211-3376. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 7/31/2018. Redacted Transcript Deadline set for 8/10/2018. Release of Transcript Restriction set for 10/9/2018. (crb)
Jul 9, 2018	228	Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Appearance of Jessica A. Stow as counsel for Plaintiffs by Baxalta GmbH, Baxalta Incorporated (Dudash, Amy)
Jul 5, 2018	227	Redacted Document (13) Docket Text: REDACTED VERSION of [225] Reply to Response to Motion by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jul 2, 2018	N/A	Oral Argument (0) Docket Text: Minute Entry for proceedings held before Judge Timothy B. Dyk Oral argument held on 7/2/2018. Pursuant to the parties stipulation, Chugai shall make available a witness or witnesses for a Rule 30(b)(6) deposition. If the deposition is taken outside the United States, it shall be taken in accordance with the appropriate foreign law. Within five days of completion of the deposition, Baxalta shall file a proposed order dismissing Chugai in accordance with the stipulation. As stated on the record, Baxaltas motion for leave to amend its complaint is GRANTED. (Court Reporter Kenneth Norris present.) (nmg)
Jun 28, 2018	223	Redacted Document (16) Docket Text: REDACTED VERSION of [216] Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew)
Jun 28, 2018	224	Redacted Document (24) Docket Text: REDACTED VERSION of [217] Declaration of Eric Alan Stone by Genentech, Inc.. (Mayo, Andrew)
Jun 28, 2018	226	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Baxalta's Sealed Reply Brief in Support of Motion to Amend the Complaint by Baxalta GmbH, Baxalta Incorporated re [225] Reply to Response to Motion (Dudash, Amy)
Jun 27, 2018	221	Amended Document (11) Docket Text: AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. Amendment to [220] Stipulation - Corrected Exhibit B. (Dudash, Amy)
Jun 27, 2018	222	Order (2) Docket Text: ORDER approving [219] STIPULATION Regarding Extension of Deadlines for Submission of Opening and Responsive Proposed Findings of Fact and Conclusions of Law with Respect to the Pending Motion for Preliminary Injunction, and Regarding Deadline for Submission of Responsive Markman Briefs. The deadlines by which plaintiffs and defendant Genentech, Inc. shall file proposed findings of fact and conclusions of law with respect to the pending motion for preliminary injunction, as originally established in the Court's June 19, 2018 oral order, are extended, with simultaneous opening papers not to exceed 25 double-spaced pages due by 6:00 p.m. EDT on July 11, 2018, and simultaneous responsive papers not to exceed 10 double-spaced pages due by 6:00 p.m. EDT on July 18, 2018. ORDER Re-setting Scheduling Order deadlines: ( Claim Construction Answering Briefs due by 7/16/2018.) Signed by Judge Timothy Belcher Dyk on 6/26/2018. (nmf)
Jun 26, 2018	219	Stipulation (2) Docket Text: STIPULATION Regarding Extension of Deadlines for Submission of Opening and Responsive Proposed Findings of Fact and Conclusions of Law with Respect to the Pending Motion for Preliminary Injunction, and Regarding Deadline for Submission of Responsive Markman Briefs, by Genentech, Inc.. (Balick, Steven)
Jun 26, 2018	220	Stipulation (Main Document) (6) Docket Text: Joint STIPULATION re Chugai Pharmaceutical Co. Ltd. by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jun 26, 2018	220	Stipulation (Exhibit A) (20) Docket Text: Joint STIPULATION re Chugai Pharmaceutical Co. Ltd. by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jun 26, 2018	220	Stipulation (Exhibit B) (11) Docket Text: Joint STIPULATION re Chugai Pharmaceutical Co. Ltd. by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jun 26, 2018	220	Stipulation (Exhibit C) (3) Docket Text: Joint STIPULATION re Chugai Pharmaceutical Co. Ltd. by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jun 26, 2018	220	Stipulation (Exhibit D) (3) Docket Text: Joint STIPULATION re Chugai Pharmaceutical Co. Ltd. by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(Dudash, Amy)
Jun 25, 2018	218	Amended Document (4) Docket Text: AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. Amendment to [42] MEMORANDUM in Support, Exhibit A - Proposed Order. (Dudash, Amy)
Jun 20, 2018	213	Transcript (89) Docket Text: Official Transcript of Motion to Dismiss held on 06-12-18 before Judge Timothy B. Dyk. Court Reporter/Transcriber Susan Migatz. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/11/2018. Redacted Transcript Deadline set for 7/23/2018. Release of Transcript Restriction set for 9/18/2018. (lad)
Jun 20, 2018	214	Transcript (374) Docket Text: Official Transcript of Preliminary Injunction Hearing (Day 1) held on 06-13-18 before Judge Timothy B. Dyk. Court Reporter/Transcriber Susan Migatz. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/11/2018. Redacted Transcript Deadline set for 7/23/2018. Release of Transcript Restriction set for 9/18/2018. (lad)
Jun 20, 2018	215	Transcript (399) Docket Text: Official Transcript of Preliminary Injunction Hearing (Day 2) held on 06-14-18 before Judge Timothy B. Dyk. Court Reporter/Transcriber Susan Migatz. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/11/2018. Redacted Transcript Deadline set for 7/23/2018. Release of Transcript Restriction set for 9/18/2018. (lad)
Jun 19, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: Oral argument regarding the motion for a preliminary injunction has been set in this matter for Monday, July 2, 2018, at 1:30 PM at the U.S. Court of Appeals for the Federal Circuit, Washington, DC. The parties shall file proposed findings of fact and conclusions of law concerning the preliminary injunction, not to exceed 25 double-spaced pages, by the close of business on July 9, 2018. The parties shall simultaneously file reply proposed findings of fact and conclusions of law, not to exceed 10 double-spaced pages, by the close of business on July 16, 2018. Ordered by Judge Timothy B. Dyk on 6/19/2018. (nmf)
Jun 19, 2018	211	Redacted Document (4) Docket Text: REDACTED VERSION of [205] Letter by Genentech, Inc.. (Balick, Steven)
Jun 19, 2018	212	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [206] Letter by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - REDACTED)(Dudash, Amy)
Jun 19, 2018	212	Redacted Document (Exhibit A - REDACTED) (1) Docket Text: REDACTED VERSION of [206] Letter by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A - REDACTED)(Dudash, Amy)
Jun 15, 2018	210	Redacted Document (Main Document) (7) Docket Text: REDACTED VERSION of [198] Letter by Genentech, Inc.. (Attachments: # (1) Exhibit 1-2)(Mayo, Andrew)
Jun 15, 2018	210	Redacted Document (Exhibit 1-2) (9) Docket Text: REDACTED VERSION of [198] Letter by Genentech, Inc.. (Attachments: # (1) Exhibit 1-2)(Mayo, Andrew)
Jun 14, 2018	N/A	Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Motion Hearing held on 6/14/2018 re [41] Motion for Preliminary Injunction. (Court Reporter Susan Marie Migatz.) (ceg)
Jun 14, 2018	207	Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [193] MOTION to Amend/Correct [1] Complaint,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Amended Complaint, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D)(Dudash, Amy)
Jun 14, 2018	207	Redacted Document (Affidavit of Amy Dudash) (2) Docket Text: REDACTED VERSION of [193] MOTION to Amend/Correct [1] Complaint,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Amended Complaint, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D)(Dudash, Amy)
Jun 14, 2018	207	Redacted Document (Amended Complaint) (14) Docket Text: REDACTED VERSION of [193] MOTION to Amend/Correct [1] Complaint,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Amended Complaint, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D)(Dudash, Amy)
Jun 14, 2018	207	Redacted Document (Exhibit B) (17) Docket Text: REDACTED VERSION of [193] MOTION to Amend/Correct [1] Complaint,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Amended Complaint, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D)(Dudash, Amy)
Jun 14, 2018	207	Redacted Document (Exhibit C) (1) Docket Text: REDACTED VERSION of [193] MOTION to Amend/Correct [1] Complaint,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Amended Complaint, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D)(Dudash, Amy)
Jun 14, 2018	207	Redacted Document (Exhibit D) (1) Docket Text: REDACTED VERSION of [193] MOTION to Amend/Correct [1] Complaint,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit of Amy Dudash, # (2) Amended Complaint, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D)(Dudash, Amy)
Jun 14, 2018	208	Redacted Document (6) Docket Text: REDACTED VERSION of [195] MEMORANDUM in Support of Motion to Amend/Correct Complaint by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jun 14, 2018	209	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [196] Letter to Honorable Timothy B. Dyk from Amy Dudash regarding Privilege Claim by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A)(Dudash, Amy)
Jun 14, 2018	209	Redacted Document (Exhibit A) (1) Docket Text: REDACTED VERSION of [196] Letter to Honorable Timothy B. Dyk from Amy Dudash regarding Privilege Claim by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A)(Dudash, Amy)
Jun 13, 2018	N/A	Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Motion Hearing held on 6/13/2018 re [41] Motion for Preliminary Injunction. (Court Reporter Susan Marie Migatz.) (ceg)
Jun 12, 2018	N/A	Oral Argument (0) Docket Text: Minute Entry for proceedings held before Judge Timothy B. Dyk - Oral Argument held on 6/12/2018. Parties to provide additional supplemental briefing with respect to Exhibit JJ by close of business on 6/13/2018. (Court Reporter Susan Marie Migatz.)(fms)
Jun 12, 2018	204	Redacted Document (Main Document) (10) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit A) (20) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit B) (21) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit C) (20) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit D) (17) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit E) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit F) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit G) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit H) (4) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit I) (15) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit J) (5) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit K) (3) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit L) (4) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit M) (7) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit N) (3) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit O) (22) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit P) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit Q) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit R) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit S) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 12, 2018	204	Redacted Document (Redacted Exhibit T) (1) Docket Text: REDACTED VERSION of [187] Letter,, to The Honorable Timothy B. Dyk from Amy M. Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Redacted Exhibit A, # (2) Redacted Exhibit B, # (3) Redacted Exhibit C, # (4) Redacted Exhibit D, # (5) Redacted Exhibit E, # (6) Redacted Exhibit F, # (7) Redacted Exhibit G, # (8) Redacted Exhibit H, # (9) Redacted Exhibit I, # (10) Redacted Exhibit J, # (11) Redacted Exhibit K, # (12) Redacted Exhibit L, # (13) Redacted Exhibit M, # (14) Redacted Exhibit N, # (15) Redacted Exhibit O, # (16) Redacted Exhibit P, # (17) Redacted Exhibit Q, # (18) Redacted Exhibit R, # (19) Redacted Exhibit S, # (20) Redacted Exhibit T)(Dudash, Amy)
Jun 11, 2018	203	Redacted Document (7) Docket Text: REDACTED VERSION of [201] Letter by Genentech, Inc.. (Mayo, Andrew)
Jun 9, 2018	202	Letter (Main Document) (5) Docket Text: Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Supplemental Claim Construction Brief for Purposes of Preliminary Injunction. (Attachments: # (1) Exhibit 1 to Supplemental Claim Construction Letter Brief, # (2) Exhibit 2 to Supplemental Claim Construction Letter Brief)(Dudash, Amy)
Jun 9, 2018	202	Letter (Exhibit 1 to Supplemental Claim Construction Letter Brief) (7) Docket Text: Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Supplemental Claim Construction Brief for Purposes of Preliminary Injunction. (Attachments: # (1) Exhibit 1 to Supplemental Claim Construction Letter Brief, # (2) Exhibit 2 to Supplemental Claim Construction Letter Brief)(Dudash, Amy)
Jun 9, 2018	202	Letter (Exhibit 2 to Supplemental Claim Construction Letter Brief) (4) Docket Text: Letter to Honorable Timothy B. Dyk from Amy M. Dudash regarding Supplemental Claim Construction Brief for Purposes of Preliminary Injunction. (Attachments: # (1) Exhibit 1 to Supplemental Claim Construction Letter Brief, # (2) Exhibit 2 to Supplemental Claim Construction Letter Brief)(Dudash, Amy)
Jun 8, 2018	197	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Letter to The Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated re [196] Letter (Dudash, Amy)
Jun 8, 2018	199	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosure of Infringement Contentions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jun 8, 2018	200	Letter (10) Docket Text: Letter to The Honorable Judge Timothy B. Dyk from Karen E. Keller - re [187] Letter,,. (Keller, Karen)
Jun 7, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: On May 29, 2018, Patients for Access to Advanced Hemophilia Therapy (PAAHT) moved for leave to file an amicus brief in opposition to plaintiffs motion for a preliminary injunction. ECF No. [182]. Plaintiffs responded with their objections to the filing of the amicus brief. ECF No. [189]. Having considered plaintiffs objections, PAAHTs motion is GRANTED. Ordered by Judge Timothy B. Dyk on 6/7/2018. (nmg)
Jun 7, 2018	N/A	Remark (0) Docket Text: NOTE: We have removed the deadline for a reply brief that was automatically generated by the system at ECF No. [190]. (nmg)
Jun 7, 2018	190	Answering Brief in Opposition (15) Docket Text: Amicus Curiae Answering Brief in Opposition to D.I. [41] MOTION for Preliminary Injunction filed by Patients for Access to Advanced Hemophilia Therapy. Modified on 6/7/2018 (nmg).
Jun 7, 2018	192	Redacted Document (1) Docket Text: REDACTED VERSION of [191] Exhibit to a Document by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jun 7, 2018	194	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Motion to Amend by Baxalta GmbH, Baxalta Incorporated re [193] MOTION to Amend/Correct [1] Complaint,, (Dudash, Amy)
Jun 6, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: The parties have raised a dispute concerning a privilege issue. No later than 5:00 PM on June 8, 2018, the parties shall file simultaneous letter briefs on this issue no longer than five double-spaced pages each. Ordered by Judge Timothy B. Dyk on 6/6/2018. (nmg)
Jun 6, 2018	189	Letter (2) Docket Text: Letter to The Honorable Timothy B. Dyk from Amy M. Dudash regarding plaintiff's submission of objections to Patents for Access to Advanced Hemophilia Therapy's ("PAAHT") Motion (D.I. 182) - re [183] Order, [182] MOTION for Leave to permit to File an Amicus Brief. (Dudash, Amy)
Jun 5, 2018	188	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Letter to The Honorable Timothy B. Dyk by Baxalta GmbH, Baxalta Incorporated re [187] Letter,, (Dudash, Amy)
Jun 1, 2018	186	Redacted Document (Main Document) (22) Docket Text: REDACTED VERSION of [180] Reply to Response to Motion,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit Amy Dudash, # (2) Exhibit A-JJ)(Dudash, Amy)
Jun 1, 2018	186	Redacted Document (Affidavit Amy Dudash) (6) Docket Text: REDACTED VERSION of [180] Reply to Response to Motion,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit Amy Dudash, # (2) Exhibit A-JJ)(Dudash, Amy)
Jun 1, 2018	186	Redacted Document (Exhibit A-JJ) (30) Docket Text: REDACTED VERSION of [180] Reply to Response to Motion,,, by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Affidavit Amy Dudash, # (2) Exhibit A-JJ)(Dudash, Amy)
May 30, 2018	183	Order (1) Docket Text: ORDER re [182] MOTION for Leave to permit to File an Amicus Brief filed by Patients for Access to Advanced Hemophilia Therapy. No later than June 6, 2018, Plaintiffs shall file a letter, not to exceed one page, containing any objections to the filing of the proposed amicus brief. Signed by Judge Timothy Belcher Dyk on 5/30/2018. (fms)
May 30, 2018	184	Transcript (17) Docket Text: Official Transcript of Telephone Conference held on 5/23/2018 before Judge Timothy Belcher Dyk. Court Reporter/Transcriber Cynthia J. Conforti, CSR, CRR, Telephone number 800.211.3376. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/20/2018. Redacted Transcript Deadline set for 7/2/2018. Release of Transcript Restriction set for 8/28/2018. (fms)
May 30, 2018	185	Order (3) Docket Text: ORDER denying the request to conduct a Rule 30(b)(6) deposition of Chugai on jurisdictional matters. See order for further details. Signed by Judge Timothy Belcher Dyk on 5/30/2018. (nmf)
May 29, 2018	182	Motion for Leave to File Amicus Brief (Main Document) (6) Docket Text: MOTION for Leave to permit Patients for Access to Advanced Hemophilia Therapy to File an Amicus Brief - filed by Patients for Access to Advanced Hemophilia Therapy. (Attachments: # (1) Proposed Amicus Curiae Brief in Opposition to Plaintiff's Motion for a Preliminary Injunction)(nmf)
May 29, 2018	182	Motion for Leave to File Amicus Brief (Proposed Amicus Curiae Brief in Opposition to Plaintiff's Motion for a Pre) (15) Docket Text: MOTION for Leave to permit Patients for Access to Advanced Hemophilia Therapy to File an Amicus Brief - filed by Patients for Access to Advanced Hemophilia Therapy. (Attachments: # (1) Proposed Amicus Curiae Brief in Opposition to Plaintiff's Motion for a Preliminary Injunction)(nmf)
May 25, 2018	176	Redacted Document (27) Docket Text: REDACTED VERSION of [160] Claim Construction Opening Brief by Genentech, Inc.. (Mayo, Andrew)
May 25, 2018	177	Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [161] Declaration of William R. Strohl, Ph.D. by Genentech, Inc.. (Attachments: # (1) Exhibit A-J)(Mayo, Andrew)
May 25, 2018	177	Redacted Document (Exhibit A-J) (30) Docket Text: REDACTED VERSION of [161] Declaration of William R. Strohl, Ph.D. by Genentech, Inc.. (Attachments: # (1) Exhibit A-J)(Mayo, Andrew)
May 25, 2018	178	Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [162] Declaration of David E. Cole by Genentech, Inc.. (Attachments: # (1) Exhibit 1-3)(Mayo, Andrew)
May 25, 2018	178	Redacted Document (Exhibit 1-3) (13) Docket Text: REDACTED VERSION of [162] Declaration of David E. Cole by Genentech, Inc.. (Attachments: # (1) Exhibit 1-3)(Mayo, Andrew)
May 25, 2018	179	Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [163] Declaration of John P. Sheehan, M.D. by Genentech, Inc.. (Attachments: # (1) Exhibit A-H)(Mayo, Andrew)
May 25, 2018	179	Redacted Document (Exhibit A-H) (30) Docket Text: REDACTED VERSION of [163] Declaration of John P. Sheehan, M.D. by Genentech, Inc.. (Attachments: # (1) Exhibit A-H)(Mayo, Andrew)
May 25, 2018	181	Certificate of Service (1) Docket Text: CERTIFICATE OF SERVICE of Baxalta's Sealed Reply in Support of Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated re [180] Reply to Response to Motion,,, (Dudash, Amy)
May 24, 2018	175	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Supplemental Responses to Plaintiffs' First Set of Interrogatories (Nos. 6-7) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen)
May 23, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Karon N. Fowler for Baxalta GmbH, Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
May 23, 2018	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Telephone Conference held on 5/23/2018. (Court Reporter present.) (sar)
May 23, 2018	174	Scheduling Order (3) Docket Text: ORDER MODIFYING SCHEDULE : All jurisdictional discovery for purposes of Defendant Chugai's pending motion to dismiss shall be completed by May 23, 2018. Set Briefing Schedule: re [41] MOTION for Preliminary Injunction (Reply Brief due 5/25/2018.) Joinder of Parties due by 6/7/2018. Amended Pleadings due by 6/7/2018. Fact Discovery completed by 10/5/2018. Expert Discovery due by 2/15/2019. A Motion Hearing is set for 6/13/2018 at 09:30 AM in Courtroom 4A at the U.S. District Court for the District of Delaware, Wilmington, DE before Judge Timothy Belcher Dyk An Oral Argument is set for 6/12/2018 at 03:30 PM in Courtroom 4A at the U.S. District Court for the District of Delaware, Wilmington, DE before Judge Timothy Belcher Dyk. Claim Construction Answering Brief due by 7/2/2018. A Markman Hearing is set for 9/13/2018 at 10:00 AM before Judge Timothy Belcher Dyk at the U.S. Court of Appeals for the Federal Circuit, Washington DC. Any party seeking leave to file a dispositive motion shall file a letter brief, not to exceed five double-spaced pages, by March 1, 2019. Date for trial to be scheduled at a later date. (See order for further details and deadlines). Signed by Judge Timothy Belcher Dyk on 5/23/18. (sar)
May 22, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: A teleconference has been set in this matter for Wednesday, May 23, 2018, at 4:00 PM. Counsel for plaintiffs shall initiate the call to chambers once all participants are on the line. Ordered by Judge Timothy B. Dyk on 5/22/2018.
May 22, 2018	168	Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [153] Declaration of David E. Cole by Genentech, Inc.. (Attachments: # (1) Exhibit 1-25)(Mayo, Andrew)
May 22, 2018	168	Redacted Document (Exhibit 1-25) (30) Docket Text: REDACTED VERSION of [153] Declaration of David E. Cole by Genentech, Inc.. (Attachments: # (1) Exhibit 1-25)(Mayo, Andrew)
May 22, 2018	169	Redacted Document (30) Docket Text: REDACTED VERSION of [154] Answering Brief in Opposition by Genentech, Inc.. (Mayo, Andrew)
May 22, 2018	170	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Karon N. Fowler - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
May 22, 2018	171	Order (1) Docket Text: ORDER granting [170] MOTION for Pro Hac Vice Appearance of Attorney Karon N. Fowler filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 5/22/2018. (fms)
May 22, 2018	172	Notice (Other) (2) Docket Text: NOTICE of Supplemental Developments Regarding Baxalta's Motion for a Preliminary Injunction, by Genentech, Inc. re [154] Answering Brief in Opposition (Balick, Steven)
May 22, 2018	173	Declaration (Main Document) (2) Docket Text: DECLARATION re [154] Answering Brief in Opposition (Supplemental Declaration of David E. Cole in Support of Genentech's Opposition to Plaintiffs' Motion for a Preliminary Injunction), by Genentech, Inc.. (Attachments: # (1) Exhibit 26-28)(Balick, Steven)
May 22, 2018	173	Declaration (Exhibit 26-28) (30) Docket Text: DECLARATION re [154] Answering Brief in Opposition (Supplemental Declaration of David E. Cole in Support of Genentech's Opposition to Plaintiffs' Motion for a Preliminary Injunction), by Genentech, Inc.. (Attachments: # (1) Exhibit 26-28)(Balick, Steven)
May 21, 2018	165	Scheduling Order (3) Docket Text: SCHEDULING ORDER: The parties shall file any comments by joint letter, not to exceed five double-spaced pages, by May 21, 2018, by 6:00 p.m. ( Joinder of Parties due by 6/7/2018., Amended Pleadings due by 6/7/2018., Fact Discovery completed by 10/5/2018., Opening Expert Reports due by 11/9/2018., Rebuttal Expert Reports due by 12/14/2018., Expert Discovery due by 2/15/2019., Reply expert reports shall be served on or before January 11, 2019. A two-day Motion Hearing on the motion for a preliminary injunction is set for 6/13/2018 at 09:30 AM in Courtroom 4A before Judge Timothy Belcher Dyk of the U.S. District Court for the District of Delaware, Wilmington, DE., AN Oral Argument on the motion to dismiss is set for 6/12/2018 at 03:30 PM before Judge Timothy Belcher Dyk at the U.S. District Court for the District of Delaware, Wilmington, DE., Claim Construction Answering Brief due by 7/2/2018., A half-day Markman Hearing is set for 9/13/2018 at 10:00 AM before Judge Timothy Belcher Dyk at the U.S. Court of Appeals for the Federal Circuit, Washington, DC.), Set Briefing Schedule: re [41] MOTION for Preliminary Injunction (Reply Brief due 5/25/2018.). Any party seeking leave to file a dispositive motion shall file a letter brief, not to exceed five double-spaced pages, by March 1, 2019. Date for trial to be scheduled at a later date. (See order for further details and deadlines). Signed by Judge Timothy Belcher Dyk on 5/18/2018. (fms)
May 21, 2018	166	Amended Document (10) Docket Text: AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. - Second Amended Joint Claim Construction Chart for '590 Patent. (Dudash, Amy)
May 21, 2018	167	Letter (6) Docket Text: Letter to Honorable Timothy B. Dyk from Baxalta Incorporated, Baxalta GmbH and Chugai Pharmaceutical Co., Ltd. regarding May 18, 2018 Proposed Order Modifying Schedule - re [165] Scheduling Order,,,,,, Set Briefing Schedule,,,,,. (Dudash, Amy)
May 18, 2018	156	Order (1) Docket Text: ORDER granting [152] MOTION for Pro Hac Vice Appearance of Attorney Julie S. Goldemberg filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Timothy Belcher Dyk on 5/18/2018. (fms)
May 18, 2018	157	Stipulation (4) Docket Text: STIPULATION Seeking to Modify Scheduling Order, by Genentech, Inc.. (Balick, Steven)
May 18, 2018	158	Claim Construction Opening Brief (27) Docket Text: CLAIM CONSTRUCTION OPENING BRIEF filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
May 18, 2018	159	Declaration (Main Document) (4) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit A) (30) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit B) (4) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit C) (30) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit D) (22) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit E) (30) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit F) (26) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit G) (6) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit H) (6) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	159	Declaration (Exhibit I) (3) Docket Text: DECLARATION re [158] Claim Construction Opening Brief of Amy Dudash by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Dudash, Amy)
May 18, 2018	164	Joinder (2) Docket Text: JOINDER by Chugai Pharmaceutical Co., Ltd., joining in [160] Claim Construction Opening Brief . (Keller, Karen)
May 16, 2018	155	Transcript (33) Docket Text: Official Transcript of Status Conference held on 5/14/2018 before Judge Dyk. Court Reporter/Transcriber Keith A. Wilkerson, 1-800-211-3376. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 6/6/2018. Redacted Transcript Deadline set for 6/18/2018. Release of Transcript Restriction set for 8/14/2018. (nmf)
May 15, 2018	152	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Julie S. Goldemberg - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
May 14, 2018	N/A	Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Timothy Belcher Dyk - Status Conference held on 5/14/2018. The Markman Hearing set for 8/2/2018 is rescheduled for 9/13/2018 at 10:00 AM at the U.S. Court of Appeals for the Federal Circuit, Washington, DC. The parties will submit additional proposed revisions to the schedule by Friday, May 18, 2018. (Court Reporter present.) (crb)
May 11, 2018	150	Order (1) Docket Text: ORDER: Going forward, the parties shall provide two copies of all filings made on the docket in this action to the following address:Chambers of Hon. Timothy B. Dyk, United States Court of Appeals for the Federal Circuit, 717 Madison Place N.W., Washington, DC 20439. Signed by Judge Timothy Belcher Dyk on 5/11/2018. (fms)
May 11, 2018	151	Order (2) Docket Text: ORDER approving [149] Stipulation Requesting Additional Pages for Preliminary Injunction Answering and Reply Briefs. Signed by Judge Timothy Belcher Dyk on 5/11/2018. (fms)
May 9, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER: Status conference to be held at 2:00 p.m., Monday, May 14, 2018, in Courtroom 203 of the U.S. Court of Appeals for the Federal Circuit, Washington, DC. The parties should be prepared to discuss the following at the status conference: resetting the date for the Markman hearing and for trial and what if any claim-construction issues will need to be addressed as part of the preliminary-injunction proceedings. The deadlines for Markman briefing are extended as stipulated at ECF No. [147] to May 18, 2018, for the opening briefs and to July 2, 2018, for the responsive briefs. Ordered by Judge Timothy B. Dyk on 5/9/2018. (nmg)
May 9, 2018	149	Stipulation (2) Docket Text: STIPULATION Requesting Additional Pages for Preliminary Injunction Answering and Reply Briefs, by Genentech, Inc.. (Balick, Steven)
May 8, 2018	148	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Anthony A. Kossiakoff, Ph.D. on May 10, 2018 filed by Genentech, Inc..(Mayo, Andrew)
May 4, 2018	N/A	Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Timothy Belcher Dyk of the U.S. Court of Appeals for Federal Circuit. Please include the initials of the Judge (TBD) after the case number on all documents filed. (rjb)
May 2, 2018	147	Stipulation (3) Docket Text: STIPULATION Seeking to Revise the Markman Briefing Schedule, by Genentech, Inc.. (Balick, Steven)
Apr 30, 2018	144	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of W. Christopher Bakewell on May 2, 2018 filed by Genentech, Inc..(Mayo, Andrew)
Apr 30, 2018	145	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sriram Krishnaswamy, Ph.D. on May 3, 2018 filed by Genentech, Inc..(Mayo, Andrew)
Apr 30, 2018	146	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Louis M. Aledort, M.D. on May 4, 2018 filed by Genentech, Inc..(Mayo, Andrew)
Apr 26, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jason C. White for Baxalta GmbH, Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Apr 26, 2018	143	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Genentech, Inc.'s Amended Initial Disclosures Pursuant to Section 3 of the Default Standard for Discovery filed by Genentech, Inc..(Balick, Steven)
Apr 24, 2018	142	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Juan Carlos Almagro, Ph.D. on April 26, 2018 filed by Genentech, Inc..(Mayo, Andrew)
Apr 23, 2018	140	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Chugai Pharmaceutical Co., Ltd.'s Responses and Objections to Plaintiffs First Set of Requests for Admission (Nos. 1-3) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen)
Apr 23, 2018	141	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech's Objections and Responses to Baxalta's First Set of Requests for Admission filed by Genentech, Inc..(Mayo, Andrew)
Apr 19, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [137] MOTION for Pro Hac Vice Appearance of Attorney Jason C. White filed by Baxalta GmbH, Baxalta Incorporated. Signed by Judge Leonard P. Stark on 4/19/18. (ntl)
Apr 18, 2018	138	Declaration (Main Document) (30) Docket Text: SEALED DECLARATION re [126] Declaration,,, of Anthony Kossiakoff by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 25 - REDACTED, # (2) Exhibit 26 - REDACTED)(Dudash, Amy)
Apr 18, 2018	138	Declaration (Exhibit 25 - REDACTED) (1) Docket Text: SEALED DECLARATION re [126] Declaration,,, of Anthony Kossiakoff by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 25 - REDACTED, # (2) Exhibit 26 - REDACTED)(Dudash, Amy)
Apr 18, 2018	138	Declaration (Exhibit 26 - REDACTED) (1) Docket Text: SEALED DECLARATION re [126] Declaration,,, of Anthony Kossiakoff by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 25 - REDACTED, # (2) Exhibit 26 - REDACTED)(Dudash, Amy)
Apr 18, 2018	139	Declaration (Main Document) (30) Docket Text: DECLARATION re [128] Declaration of Sriram Krishnaswamy - REDACTED by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 5 - REDACTED, # (2) Exhibit 7 - REDACTED)(Dudash, Amy)
Apr 18, 2018	139	Declaration (Exhibit 5 - REDACTED) (1) Docket Text: DECLARATION re [128] Declaration of Sriram Krishnaswamy - REDACTED by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 5 - REDACTED, # (2) Exhibit 7 - REDACTED)(Dudash, Amy)
Apr 18, 2018	139	Declaration (Exhibit 7 - REDACTED) (1) Docket Text: DECLARATION re [128] Declaration of Sriram Krishnaswamy - REDACTED by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 5 - REDACTED, # (2) Exhibit 7 - REDACTED)(Dudash, Amy)
Apr 17, 2018	137	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jason C. White - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Apr 16, 2018	131	Amended Document (11) Docket Text: AMENDED DOCUMENT by Baxalta GmbH, Baxalta Incorporated. Amendment to [123] Claim Construction Chart . (Dudash, Amy)
Apr 16, 2018	132	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Guy Young on April 25, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 16, 2018	133	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jerry Hausman on April 18, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 16, 2018	134	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Michael Callaghan on April 20, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 16, 2018	135	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of William Strohl on April 18, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 16, 2018	136	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of John Sheehan on April 23, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 12, 2018	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: As per the request of counsel, D.I. 126 has been placed under seal. (etg)
Apr 11, 2018	124	Declaration (Main Document) (30) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 1) (30) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 2) (3) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 3) (3) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 4) (4) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 8) (6) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 9) (17) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 10) (18) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 11) (4) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 12) (21) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 13) (10) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 14) (2) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 15) (30) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 16) (3) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 17) (5) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 18) (8) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 19) (23) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 20) (20) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 21) (3) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 22) (18) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 23) (11) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 24) (9) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	124	Declaration (Exhibit 25) (19) Docket Text: DECLARATION - Rebuttal of Juan Carlos Almagro, Ph.D., in Support of Plaintiffs' Reply Brief for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 8, # (6) Exhibit 9, # (7) Exhibit 10, # (8) Exhibit 11, # (9) Exhibit 12, # (10) Exhibit 13, # (11) Exhibit 14, # (12) Exhibit 15, # (13) Exhibit 16, # (14) Exhibit 17, # (15) Exhibit 18, # (16) Exhibit 19, # (17) Exhibit 20, # (18) Exhibit 21, # (19) Exhibit 22, # (20) Exhibit 23, # (21) Exhibit 24, # (22) Exhibit 25)(Dudash, Amy)
Apr 11, 2018	129	Exhibit to a Document (Main Document) (2) Docket Text: EXHIBIT re [128] Declaration Exhibit 1 by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 2, # (2) Exhibit 3, # (3) Exhibit 4, # (4) Exhibit 6, # (5) Exhibit 8)(Dudash, Amy)
Apr 11, 2018	129	Exhibit to a Document (Exhibit 2) (7) Docket Text: EXHIBIT re [128] Declaration Exhibit 1 by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 2, # (2) Exhibit 3, # (3) Exhibit 4, # (4) Exhibit 6, # (5) Exhibit 8)(Dudash, Amy)
Apr 11, 2018	129	Exhibit to a Document (Exhibit 3) (7) Docket Text: EXHIBIT re [128] Declaration Exhibit 1 by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 2, # (2) Exhibit 3, # (3) Exhibit 4, # (4) Exhibit 6, # (5) Exhibit 8)(Dudash, Amy)
Apr 11, 2018	129	Exhibit to a Document (Exhibit 4) (30) Docket Text: EXHIBIT re [128] Declaration Exhibit 1 by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 2, # (2) Exhibit 3, # (3) Exhibit 4, # (4) Exhibit 6, # (5) Exhibit 8)(Dudash, Amy)
Apr 11, 2018	129	Exhibit to a Document (Exhibit 6) (27) Docket Text: EXHIBIT re [128] Declaration Exhibit 1 by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 2, # (2) Exhibit 3, # (3) Exhibit 4, # (4) Exhibit 6, # (5) Exhibit 8)(Dudash, Amy)
Apr 11, 2018	129	Exhibit to a Document (Exhibit 8) (30) Docket Text: EXHIBIT re [128] Declaration Exhibit 1 by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 2, # (2) Exhibit 3, # (3) Exhibit 4, # (4) Exhibit 6, # (5) Exhibit 8)(Dudash, Amy)
Apr 6, 2018	116	Redacted Document (30) Docket Text: REDACTED VERSION of [108] Declaration (of Jerry A. Hausman, Ph.D.) by Genentech, Inc.. (Mayo, Andrew)
Apr 6, 2018	117	Redacted Document (30) Docket Text: REDACTED VERSION of [109] Declaration (of Michael U. Callaghan, M.D.) by Genentech, Inc.. (Mayo, Andrew)
Apr 6, 2018	118	Redacted Document (30) Docket Text: REDACTED VERSION of [110] Declaration (of Guy A. Young, M.D.) by Genentech, Inc.. (Mayo, Andrew)
Apr 6, 2018	119	Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [111] Declaration,,, (of John P. Sheehan, M.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-Z, # (2) Exhibit AA-KK)(Mayo, Andrew)
Apr 6, 2018	119	Redacted Document (Exhibit A-Z) (30) Docket Text: REDACTED VERSION of [111] Declaration,,, (of John P. Sheehan, M.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-Z, # (2) Exhibit AA-KK)(Mayo, Andrew)
Apr 6, 2018	119	Redacted Document (Exhibit AA-KK) (30) Docket Text: REDACTED VERSION of [111] Declaration,,, (of John P. Sheehan, M.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-Z, # (2) Exhibit AA-KK)(Mayo, Andrew)
Apr 6, 2018	120	Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [112] Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-K, # (2) Exhibit L-Z, # (3) Exhibit AA-LL, # (4) Exhibit MM-GGG, # (5) Exhibit HHH-SSS, # (6) Exhibit TTT-BBBB)(Mayo, Andrew)
Apr 6, 2018	120	Redacted Document (Exhibit A-K) (30) Docket Text: REDACTED VERSION of [112] Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-K, # (2) Exhibit L-Z, # (3) Exhibit AA-LL, # (4) Exhibit MM-GGG, # (5) Exhibit HHH-SSS, # (6) Exhibit TTT-BBBB)(Mayo, Andrew)
Apr 6, 2018	120	Redacted Document (Exhibit L-Z) (30) Docket Text: REDACTED VERSION of [112] Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-K, # (2) Exhibit L-Z, # (3) Exhibit AA-LL, # (4) Exhibit MM-GGG, # (5) Exhibit HHH-SSS, # (6) Exhibit TTT-BBBB)(Mayo, Andrew)
Apr 6, 2018	120	Redacted Document (Exhibit AA-LL) (30) Docket Text: REDACTED VERSION of [112] Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-K, # (2) Exhibit L-Z, # (3) Exhibit AA-LL, # (4) Exhibit MM-GGG, # (5) Exhibit HHH-SSS, # (6) Exhibit TTT-BBBB)(Mayo, Andrew)
Apr 6, 2018	120	Redacted Document (Exhibit MM-GGG) (30) Docket Text: REDACTED VERSION of [112] Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-K, # (2) Exhibit L-Z, # (3) Exhibit AA-LL, # (4) Exhibit MM-GGG, # (5) Exhibit HHH-SSS, # (6) Exhibit TTT-BBBB)(Mayo, Andrew)
Apr 6, 2018	120	Redacted Document (Exhibit HHH-SSS) (30) Docket Text: REDACTED VERSION of [112] Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-K, # (2) Exhibit L-Z, # (3) Exhibit AA-LL, # (4) Exhibit MM-GGG, # (5) Exhibit HHH-SSS, # (6) Exhibit TTT-BBBB)(Mayo, Andrew)
Apr 6, 2018	120	Redacted Document (Exhibit TTT-BBBB) (30) Docket Text: REDACTED VERSION of [112] Declaration,,,,,, (of William R. Strohl, Ph.D.) by Genentech, Inc.. (Attachments: # (1) Exhibit A-K, # (2) Exhibit L-Z, # (3) Exhibit AA-LL, # (4) Exhibit MM-GGG, # (5) Exhibit HHH-SSS, # (6) Exhibit TTT-BBBB)(Mayo, Andrew)
Apr 6, 2018	121	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gallia Levy (REVISED) on April 5, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 6, 2018	122	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gina Chapman (REVISED) on April 6, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 6, 2018	123	Claim Construction Chart (11) Docket Text: CLAIM Construction Chart by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Apr 4, 2018	114	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gallia Levy on April 5, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 4, 2018	115	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gina Chapman on April 6, 2018 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Apr 3, 2018	113	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Chugai Pharmaceutical Co., Ltd.'s First Amended Preliminary Identification of Claim Terms that Need to be Construed filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen)
Mar 29, 2018	106	Notice (Other) (3) Docket Text: NOTICE of Asserted Claim In Baxalta's Opening Memorandum In Support of Its Motion for a Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated re [42] MEMORANDUM in Support, (Dudash, Amy)
Mar 29, 2018	107	Exhibit to a Document (2) Docket Text: Amended EXHIBIT re [46] Declaration, Amended Exhibit B to Declaration of Dr. Aledort by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Mar 23, 2018	97	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH's First Set of Requests for Admission to Chugai Pharmaceutical Co., Ltd. (Nos. 1-6) and Baxalta Incorporated and Baxalta GmbH's First Set of Requests for Admission to Genentech, Inc. (Nos. 1-3) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Mar 23, 2018	98	Declaration (11) Docket Text: DECLARATION of Gallia Levy, M.D., Ph.D. in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew)
Mar 23, 2018	99	Declaration (5) Docket Text: DECLARATION of Harvey Liverman in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew)
Mar 23, 2018	101	Redacted Document (8) Docket Text: REDACTED VERSION of [100] Declaration of Gina Chapman in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew)
Mar 23, 2018	103	Redacted Document (4) Docket Text: REDACTED VERSION of [102] Declaration of Greg Hogan in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew)
Mar 23, 2018	105	Redacted Document (5) Docket Text: REDACTED VERSION of [104] Declaration of Chelsey Serrano in Opposition to Plaintiffs' Motion for a Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew)
Mar 9, 2018	95	SO ORDERED (5) Docket Text: SO ORDERED, re [93] Amended Stipulation and Scheduling Order -- the Markman Hearing is rescheduled for 8/2/2018 at 10:00 AM in Courtroom 6B. Signed by Judge Leonard P. Stark on 3/9/18. (ntl)
Mar 9, 2018	96	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH Responses and Objections to Genentech, Inc.'s Second Set of Interrogatories and Baxalta Incorporated and Baxalta GmbH's Responses and Objections to Genentech, Inc.'s Second Set of Requests for the Production of Documents and Things filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Mar 5, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [92] MOTION for Pro Hac Vice Appearance of Attorney James V. Razick filed by Genentech, Inc. Signed by Judge Leonard P. Stark on 3/5/18. (ntl)
Mar 5, 2018	94	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH's Responses and Objections to Genentech's Notice of Deposition re [90] Notice of Service filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Mar 2, 2018	92	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James V. Razick - filed by Genentech, Inc.. (Mayo, Andrew)
Mar 2, 2018	93	Stipulation (5) Docket Text: Joint STIPULATION Regarding Revised Schedule for Plaintiffs' Motion for Preliminary Injunction by Genentech, Inc.. (Mayo, Andrew)
Mar 1, 2018	91	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Non-Parties Shire LLC, Shire US, Inc., and Thomas A. Larmondra's Objections and Responses to Genentech, Inc.'s Subpoenas re [83] Notice of Service, [80] Notice of Service, [82] Notice of Service filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Feb 28, 2018	N/A	Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Feb 28, 2018	90	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Genentech's Notice of Deposition of Plaintiffs Baxalta Incorporated and Baxalta GmbH Related to Plaintiffs' Motion for Preliminary Injunction filed by Genentech, Inc..(Mayo, Andrew)
Feb 26, 2018	89	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Chugai Pharmaceutical Co., Ltd.'s Preliminary Identification of Claim Terms and Proposed Constructions filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen)
Feb 23, 2018	86	Transcript (23) Docket Text: Official Transcript of Teleconference held on 2/12/18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/16/2018. Redacted Transcript Deadline set for 3/26/2018. Release of Transcript Restriction set for 5/24/2018. (kjm)
Feb 23, 2018	87	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Genentech, Inc.'s Preliminary Identification of Claim Terms and Proposed Constructions filed by Genentech, Inc..(Mayo, Andrew)
Feb 23, 2018	88	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Feb 19, 2018	85	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Chugai Pharmaceutical Co., Ltd.'s Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-20) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen)
Feb 16, 2018	84	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Objections and Responses to Baxalta's First Set of Interrogatories (Nos. 1-20) filed by Genentech, Inc..(Mayo, Andrew)
Feb 12, 2018	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 2/12/2018. Discussion on the disputed item listed in the Joint Agenda submission; extending the briefing schedule regarding the preliminary injunction and amending the schedule. The court will set a 2-day Hearing Re: Preliminary Injunction on 6/13/2018 at 9:30 AM through 6/14/2018. The court ordered the parties to file an Amended Scheduling Order as discussed during the Teleconference. (Court Reporter: Kevin Maurer.) (asw)
Feb 12, 2018	N/A	Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: An Oral Argument (2 days) re [41] Motion for Preliminary Injunction is set for 6/13/2018 at 9:30 AM in Courtroom 4A before Judge Gregory M. Sleet. (mdb)
Feb 12, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Stephen D. Keane for Chugai Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
Feb 9, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [81] MOTION for Pro Hac Vice Appearance of Attorney Stephen D. Keane filed by Chugai Pharmaceutical Co., Ltd. Ordered by Judge Gregory M. Sleet on 2/9/2018. (mdb)
Feb 9, 2018	82	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoenas to Shire LLC filed by Genentech, Inc..(Balick, Steven)
Feb 9, 2018	83	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoenas to Shire US Inc. filed by Genentech, Inc..(Balick, Steven)
Feb 8, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jesse T. Dyer for Baxalta GmbH,Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Feb 8, 2018	78	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoena to Haematologic Technologies, Inc. filed by Genentech, Inc..(Mayo, Andrew)
Feb 8, 2018	79	Letter (1) Docket Text: Letter to The Honorable Gregory M. Sleet from Steven J. Balick regarding the Parties' Joint Agenda for the Teleconference on February 12, 2018 at 10:00 a.m.. (Balick, Steven)
Feb 8, 2018	80	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Subpoenas to Thomas A. Larmondra filed by Genentech, Inc..(Mayo, Andrew)
Feb 8, 2018	81	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stephen D. Keane - filed by Chugai Pharmaceutical Co., Ltd.. (Keller, Karen)
Feb 7, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [75] MOTION for Pro Hac Vice Appearance of Attorney Jesse T. Dyer filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 2/7/2018. (mdb)
Feb 7, 2018	77	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Second Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH (Nos. 99-101) and Genentech, Inc.'s First Set of Interrogatories (Nos. 3-11) filed by Genentech, Inc..(Mayo, Andrew)
Feb 6, 2018	N/A	Oral Order (0) Docket Text: ORAL ORDER - A Discovery Dispute Telephone Conference (#1) is set for Monday, February 12, 2018 at 10:00 AM (EST). Counsel for the plaintiffs shall arrange the call and contact Chambers at 302-573-4559 once all parties are on the line. A non-argumentative Joint Agenda Letter (see www.ded.uscourts.gov for an example) is due by noon on Thursday, February 8, 2018. Ordered by Judge Gregory M. Sleet on 2/6/2018. (mdb)
Feb 6, 2018	75	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jesse T. Dyer - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Feb 6, 2018	76	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s Notice of Subpoenas to Kilpatrick Townsend & Stockton LLP filed by Genentech, Inc..(Mayo, Andrew)
Jan 31, 2018	74	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH's Supplemental Responses and Objections to Genetech, Inc.'s Interrogatories Nos. 1-2 and Requests for Admission Nos. 3, 4, 7 and 8 filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 22, 2018	73	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Chugai Pharmaceutical Co., Ltd.'s Identification of Claim Terms that Need to be Construed filed by Chugai Pharmaceutical Co., Ltd..(Fry, David)
Jan 19, 2018	70	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' List of Claim Terms in Need of Construction filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 19, 2018	71	Notice to Take Deposition (19) Docket Text: NOTICE to Take Deposition of Genentech, Inc. and Chugai Pharmaceutical Co., Ltd. on mutually agreeable date in accordance with the scheduling order filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 19, 2018	72	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech's Identification of Claim Terms that Need to be Construed filed by Genentech, Inc..(Mayo, Andrew)
Jan 17, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sanjay K. Murthy for Baxalta GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
Jan 17, 2018	69	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (1-20) filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 16, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [68] MOTION for Pro Hac Vice Appearance of Attorney Sanjay K. Murthy filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 1/16/2018. (mdb)
Jan 12, 2018	68	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sanjay K. Murthy - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 10, 2018	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [65] MOTION for Pro Hac Vice Appearance of Attorney Caroline S. Lourgos filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 1/10/2018. (mdb)
Jan 10, 2018	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Caroline Lourgos for Baxalta GmbH,Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Jan 10, 2018	66	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GmbH Responses and Objections to Genentech, Inc.'s Discovery Requests Related to Plaintiffs' Motion for a Preliminary Injunction filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 10, 2018	67	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech's Objections and Responses to Plaintiffs' Expedited Requests for Production filed by Genentech, Inc..(Balick, Steven)
Jan 9, 2018	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 6/29/2018 at 11:00 AM Eastern Time before Judge Mary Pat Thynge to discuss the status of the case, the parties to be involved in mediation in March 2019 and submissions. Ordered by Judge Mary Pat Thynge on 1/9/18. (cak)
Jan 9, 2018	65	Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Caroline S. Lourgos - filed by Baxalta GmbH, Baxalta Incorporated. (Dudash, Amy)
Jan 5, 2018	61	SO ORDERED (5) Docket Text: SO ORDERED - re [60] Stipulation and Proposed Scheduling Order re Motion for Preliminary Injunction ([41]): Answering Brief due 4/6/2018, Reply Brief due 4/24/2018, Oral Argument is set for 5/24/2018 at 09:00 AM in Courtroom 4A. See stipulation for more details. The January 5, 2018 telephone conference is CANCELLED. Signed by Judge Gregory M. Sleet on 1/5/20158. (mdb)
Jan 5, 2018	62	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Expedited Requests for Production of Documents and Things to Defendant (Nos. 1-13) Relating to the Motion for Preliminary Injunction filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Jan 5, 2018	63	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech's Discovery Requests Related to Plaintiffs' Motion for a Preliminary Injunction filed by Genentech, Inc..(Mayo, Andrew)
Jan 4, 2018	60	Stipulation (5) Docket Text: Joint STIPULATION Regarding Scheduling for Plaintiffs' Motion for Preliminary Injunction re Oral Order,, Set/Reset Hearings by Baxalta Incorporated. (Dudash, Amy)
Jan 2, 2018	59	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Baxalta Incorporated and Baxalta GMBH Responses and Objections to Genentech, Inc.'s First Set of Requests for the Production of Documents and Things filed by Baxalta GmbH, Baxalta Incorporated.(Dudash, Amy)
Dec 22, 2017	58	Transcript (14) Docket Text: Official Transcript of Telephone Conference held on 12 18 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/12/2018. Redacted Transcript Deadline set for 1/22/2018. Release of Transcript Restriction set for 3/22/2018. (kjm)
Dec 21, 2017	55	Redacted Document (30) Docket Text: REDACTED VERSION of [42] MEMORANDUM in Support of its Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) Modified on 12/21/2017 (mdb).
Dec 21, 2017	56	Redacted Document (4) Docket Text: REDACTED VERSION of [Proposed] Preliminary Injunction Order by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) Modified on 12/21/2017 (mdb).
Dec 21, 2017	57	Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [43] Declaration of W. Christopher Bakewell Regarding Irreparable Harm and Balance of Hardships in Support of Plaintiffs' Memorandum in Support of Their Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Public Versions of Exhibits M, EE, JJ, and PP)(Connolly, Colm) Modified on 12/21/2017 (mdb).
Dec 21, 2017	57	Redacted Document (Public Versions of Exhibits M, EE, JJ, and PP) (5) Docket Text: REDACTED VERSION of [43] Declaration of W. Christopher Bakewell Regarding Irreparable Harm and Balance of Hardships in Support of Plaintiffs' Memorandum in Support of Their Motion for Preliminary Injunction by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Public Versions of Exhibits M, EE, JJ, and PP)(Connolly, Colm) Modified on 12/21/2017 (mdb).
Dec 20, 2017	N/A	Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: A Telephone Conference re: Motion for Preliminary Injunction is TENTATIVELY set for 1/5/2018 at 10:00 AM before Judge Gregory M. Sleet. (asw)
Dec 20, 2017	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael J. Abernathy and Christopher J Betti for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
Dec 20, 2017	54	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-107) filed by Chugai Pharmaceutical Co., Ltd..(Fry, David)
Dec 19, 2017	N/A	Oral Order (0) Docket Text: ORAL ORDER CANCELLING TELECONFERENCE: The Status Telephone Conference regarding [41] Motion for Preliminary Injunction previously set for Friday, December 22, 2017 at 3:00 PM is CANCELLED. The parties shall submit a Stipulation with a proposed schedule and include a date the parties are available to attend a hearing on the Motion for Preliminary Injunction. If the parties are unable to agree on a proposed schedule, the court shall set a Telephone Conference on Friday, January 5, 2018 at 10:00 AM. The parties shall contact chambers if a Teleconference is not necessary. Ordered by Judge Gregory M. Sleet on 12/19/2017. (asw)
Dec 18, 2017	N/A	Oral Order (0) Docket Text: ORAL ORDER re [41] Motion for Preliminary Injunction - A Telephone Conference is set for today, December 18, 2017 at 2:00 PM (EST). The plaintiffs shall arrange the call and contact Chambers at 302-573-4559 once all parties are on the line. Ordered by Judge Gregory M. Sleet on 12/18/2017. (mdb)
Dec 18, 2017	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 12/18/2017, (A Status Telephone Conference regarding the Motion for Preliminary Injunction ([41]) is set for Friday, December 22, 2017 at 3:00 PM. Counsel for plaintiffs shall arrange the call and contact Chambers at 302-573-4559 once all parties are on the line. (Court Reporter Kevin Maurer.) (mdb)
Dec 18, 2017	51	Notice of Appearance (2) Docket Text: NOTICE of Appearance by Jody Barillare on behalf of All Plaintiffs (Barillare, Jody)
Dec 18, 2017	52	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Preliminary Invalidity Contentions filed by Chugai Pharmaceutical Co., Ltd..(Fry, David)
Dec 18, 2017	53	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech's Objections and Responses to Baxalta's First Set of Requests for Production filed by Genentech, Inc..(Mayo, Andrew)
Dec 15, 2017	50	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genetech's Preliminary Invalidity Contentions filed by Genentech, Inc..(Mayo, Andrew)
Dec 14, 2017	41	Motion for Preliminary Injunction (3) Docket Text: MOTION for Preliminary Injunction - filed by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm)
Dec 14, 2017	44	Exhibit to a Document (Main Document) (6) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit B) (11) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit C) (5) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit D) (30) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit E) (5) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit F) (9) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit G) (6) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit H) (14) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit I) (2) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit J) (5) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit K) (12) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit L) (30) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit N) (30) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit O) (3) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit P) (4) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit Q) (3) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit R) (3) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	44	Exhibit to a Document (Exhibit S) (7) Docket Text: EXHIBIT A re [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Main Document) (13) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit U) (10) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit V) (6) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit W) (7) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit X) (7) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit Y) (8) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit Z) (4) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit AA) (4) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit BB) (4) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit CC) (15) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit DD) (4) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit FF) (2) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit GG) (5) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit HH) (30) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit II) (2) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit KK) (8) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit LL) (6) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit MM) (30) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit NN) (4) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit OO) (7) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit QQ) (5) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit RR) (9) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit SS) (8) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit TT) (7) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit UU) (7) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit VV) (7) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	45	Exhibit to a Document (Exhibit WW) (10) Docket Text: EXHIBIT T re [44] Exhibit to a Document, [43] Declaration by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit U, # (2) Exhibit V, # (3) Exhibit W, # (4) Exhibit X, # (5) Exhibit Y, # (6) Exhibit Z, # (7) Exhibit AA, # (8) Exhibit BB, # (9) Exhibit CC, # (10) Exhibit DD, # (11) Exhibit FF, # (12) Exhibit GG, # (13) Exhibit HH, # (14) Exhibit II, # (15) Exhibit KK, # (16) Exhibit LL, # (17) Exhibit MM, # (18) Exhibit NN, # (19) Exhibit OO, # (20) Exhibit QQ, # (21) Exhibit RR, # (22) Exhibit SS, # (23) Exhibit TT, # (24) Exhibit UU, # (25) Exhibit VV, # (26) Exhibit WW)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Main Document) (9) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit A) (30) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit B) (3) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit C) (9) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit D) (30) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit E) (18) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit F) (2) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit G) (3) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit H) (9) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit I) (2) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit J) (5) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit K) (11) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit L) (10) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit M) (11) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit N) (17) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	46	Declaration (Exhibit O) (10) Docket Text: DECLARATION of Dr. Louis M. Aledort re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Main Document) (30) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit A) (12) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit B) (30) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit C) (3) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit D) (3) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit E) (11) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit F) (11) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit H) (14) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit I) (30) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit K) (30) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit L) (22) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit M) (12) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit N) (30) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit O) (6) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit P) (5) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit Q) (17) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit R) (4) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit S) (4) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit T) (9) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit U) (17) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit V) (4) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit W) (3) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit X) (3) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit Y) (4) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit Z) (30) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	47	Declaration (Exhibit AA) (4) Docket Text: DECLARATION of Krishnaswamy, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit K, # (10) Exhibit L, # (11) Exhibit M, # (12) Exhibit N, # (13) Exhibit O, # (14) Exhibit P, # (15) Exhibit Q, # (16) Exhibit R, # (17) Exhibit S, # (18) Exhibit T, # (19) Exhibit U, # (20) Exhibit V, # (21) Exhibit W, # (22) Exhibit X, # (23) Exhibit Y, # (24) Exhibit Z, # (25) Exhibit AA)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Main Document) (28) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit A) (4) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit B) (20) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit C) (30) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit D) (25) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit E) (30) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit F) (4) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit G) (11) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit H) (10) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit I) (9) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit J) (22) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit K) (24) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit L) (8) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit M) (9) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit N) (11) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit O) (17) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit P) (8) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit Q) (9) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit R) (24) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit S) (6) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit T) (9) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit U) (30) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit V) (9) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit W) (5) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit X) (27) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit Y) (30) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit Z) (12) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit AA) (9) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit BB) (11) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit CC) (10) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit DD) (10) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit EE) (14) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit FF) (10) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit GG) (30) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	48	Declaration (Exhibit HH) (9) Docket Text: DECLARATION of Anthony A. Kossiakoff, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Main Document) (30) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit A) (14) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit B) (30) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit C) (3) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit D) (17) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit E) (5) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit F) (7) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit G) (18) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit H) (10) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit I) (8) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit J) (7) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit K) (2) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 14, 2017	49	Declaration (Exhibit L) (18) Docket Text: DECLARATION of Juan Carlos Almagro, Ph.D. re [42] MEMORANDUM in Support by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L)(Connolly, Colm) Modified on 12/15/2017 (mdb).
Dec 12, 2017	40	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Amy Michele Dudash on behalf of All Plaintiffs (Dudash, Amy)
Nov 17, 2017	39	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosure of Infringement Contentions Pursuant to October 11, 2017 Scheduling Order filed by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm)
Nov 13, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [38] (Proposed) Stipulated Protective Order filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 11/13/2017. (mdb)
Nov 9, 2017	38	Proposed Order (30) Docket Text: PROPOSED ORDER - Stipulated Protective Order by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm)
Nov 6, 2017	37	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Chugai Pharmaceutical Co., Ltd.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen)
Nov 3, 2017	36	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Genentech, Inc.'s Initial Disclosures Pursuant to Section 3 of the Default Standard for Discovery filed by Genentech, Inc..(Balick, Steven)
Nov 2, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [34] STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to November 9, 2017 filed by Chugai Pharmaceutical Co., Ltd.. Ordered by Judge Gregory M. Sleet on 11/2/2017. (mdb)
Nov 2, 2017	34	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to November 9, 2017 - filed by Chugai Pharmaceutical Co., Ltd.. (Shaw, John)
Nov 2, 2017	35	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Genentech, Inc.'s First Set of Requests for the Production of Documents and Things to Baxalta Incorporated and Baxalta GmbH filed by Genentech, Inc..(Mayo, Andrew)
Oct 26, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [32] Stipulation Seeking to Extend the Deadline by which the Parties Must Submit a Proposed Protective Order filed by Genentech, Inc.. Ordered by Judge Gregory M. Sleet on 10/26/2017. (mdb)
Oct 24, 2017	33	Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 11/30/2017 at 11:00 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 10/24/17. (cak)
Oct 23, 2017	N/A	Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
Oct 23, 2017	32	Stipulation (2) Docket Text: STIPULATION Seeking to Extend the Deadline by which the Parties Must Submit a Proposed Protective Order, by Genentech, Inc.. (Balick, Steven)
Oct 17, 2017	31	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-107) filed by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm)
Oct 12, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [30] Scheduling Order: Case referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and Amended Pleadings due by 6/7/2018., Claim Construction Opening Briefs due by 5/11/2018., Claim Construction Answering Briefs due by 6/15/2018., A Markman Hearing (1/2 day) is set for 7/16/2018 at 09:30 AM in Courtroom 4A., Fact Discovery completed by 8/31/2018., Opening Expert Reports due by 10/5/2018., Rebuttal Expert Reports due by 11/9/2018., Reply Expert Reports due by 12/7/2018., Expert Discovery due by 1/31/2019., Opening Summary Judgment Letter Briefs due by 2/14/2019., Answering Letter Briefs due 2/28/2019., Reply Letter Briefs due 3/7/2019., Proposed Pretrial Order due by 8/16/2019., A Final Pretrial Conference is set for 8/26/2019 at 10:00 AM in Courtroom 4A., and a 7-day Jury Trial is set for 9/9/2019 at 09:30 AM in Courtroom 4A. See Scheduling Order ([30]) for more details). Ordered by Judge Gregory M. Sleet on 10/12/2017. (mdb)
Oct 11, 2017	30	Letter (Main Document) (1) Docket Text: Letter to The Honorable Gregory M. Sleet from Colm F. Connolly regarding jointly submitting a scheduling order for the Court's consideration - re Oral Order,,. (Attachments: # (1) Text of Proposed Order - Scheduling Order)(Connolly, Colm)
Oct 11, 2017	30	Letter (Text of Proposed Order - Scheduling Order) (6) Docket Text: Letter to The Honorable Gregory M. Sleet from Colm F. Connolly regarding jointly submitting a scheduling order for the Court's consideration - re Oral Order,,. (Attachments: # (1) Text of Proposed Order - Scheduling Order)(Connolly, Colm)
Oct 4, 2017	N/A	Oral Order (0) Docket Text: ORAL ORDER re [17] Joint Status Report - The parties' proposed schedule is ADOPTED, with the following additions: The Markman Hearing (1/2 day) is set for 7/16/2018 at 9:30 AM in Courtroom 4A, the Final Pretrial Conference is set for 8/26/2019 at 10:00 AM in Courtroom 4A, and a 7-day Jury Trial is set for 9/9/2019 at 9:30 AM in Courtroom 4A. This case is referred to the Magistrate Judge for exploring ADR. The plaintiff shall file an amended scheduling order incorporating the full case schedule by 10/11/2017. Ordered by Judge Gregory M. Sleet on 10/4/2017. (mdb)
Oct 4, 2017	29	Reply Brief (15) Docket Text: REPLY BRIEF re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Chugai Pharmaceutical Co., Ltd.. (Keller, Karen)
Oct 2, 2017	28	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Chugai Pharmaceutical Co., Ltd.'s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Chugai Pharmaceutical Co., Ltd..(Keller, Karen)
Sep 29, 2017	26	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm)
Sep 29, 2017	27	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Genentech, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Genentech, Inc..(Mayo, Andrew)
Sep 27, 2017	24	Answering Brief in Opposition (24) Docket Text: ANSWERING BRIEF in Opposition re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Baxalta GmbH, Baxalta Incorporated.Reply Brief due date per Local Rules is 10/4/2017. (Connolly, Colm)
Sep 27, 2017	25	Declaration (Main Document) (3) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 1) (30) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 2) (4) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 3) (2) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 4) (4) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 5) (4) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 6) (3) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 7) (4) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 8) (14) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 9) (4) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 10) (17) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 11) (20) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 27, 2017	25	Declaration (Exhibit 12) (14) Docket Text: DECLARATION of Amanda S. Williamson re [24] Answering Brief in Opposition by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Connolly, Colm) Modified on 10/2/2017 (mdb).
Sep 26, 2017	23	Letter (2) Docket Text: Letter to The Honorable Gregory M. Sleet from David M. Fry. (Fry, David)
Sep 20, 2017	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David C. Doyle and Brian M. Kramer for Chugai Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
Sep 19, 2017	N/A	Oral Order (0) Docket Text: ORAL ORDER re [17] Joint Status Report - Because defendant Chugai Pharmaceutical Co., Ltd. did not participate in the telephone conference prior to submitting the joint status report, defendant Chugai shall file a letter indicating their positions on the contents of the joint status report and proposed schedule within seven days of this order. Ordered by Judge Gregory M. Sleet on 9/19/2017. (mdb)
Sep 15, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [22] MOTION for Pro Hac Vice Appearance of Attorney David C. Doyle and Brian M. Kramer filed by Chugai Pharmaceutical Co., Ltd.. Ordered by Judge Gregory M. Sleet on 9/15/2017. (mdb)
Sep 14, 2017	22	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David C. Doyle and Brian M. Kramer - filed by Chugai Pharmaceutical Co., Ltd.. (Keller, Karen)
Sep 13, 2017	18	Motion to Dismiss/Lack of Personal Jurisdiction (Main Document) (1) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Over the Person - filed by Chugai Pharmaceutical Co., Ltd.. (Attachments: # (1) Text of Proposed Order)(Fry, David)
Sep 13, 2017	18	Motion to Dismiss/Lack of Personal Jurisdiction (Text of Proposed Order) (1) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Over the Person - filed by Chugai Pharmaceutical Co., Ltd.. (Attachments: # (1) Text of Proposed Order)(Fry, David)
Sep 13, 2017	19	Opening Brief in Support (16) Docket Text: OPENING BRIEF in Support re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Chugai Pharmaceutical Co., Ltd..Answering Brief/Response due date per Local Rules is 9/27/2017. (Fry, David)
Sep 13, 2017	20	Declaration (5) Docket Text: DECLARATION of Tetsuya Yamaguchi re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person by Chugai Pharmaceutical Co., Ltd.. (Fry, David) Modified on 9/14/2017 (mdb).
Sep 13, 2017	21	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd. for Chugai Pharmaceutical Co., Ltd. filed by Chugai Pharmaceutical Co., Ltd.. (Fry, David)
Aug 14, 2017	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicolas P. Groombridge for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Aug 4, 2017	15	Status Report (14) Docket Text: Joint STATUS REPORT by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm)
Aug 4, 2017	16	Proposed Order (9) Docket Text: PROPOSED ORDER - Scheduling Order by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm)
Aug 4, 2017	17	Status Report (14) Docket Text: Amended STATUS REPORT (Submitted Jointly) by Baxalta GmbH, Baxalta Incorporated. (Connolly, Colm) Modified on 8/14/2017 (mdb).
Jul 21, 2017	14	Answer to Counterclaim (26) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Baxalta GmbH, Baxalta Incorporated.(Connolly, Colm)
Jul 10, 2017	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer Gordon, David E. Cole, Kenneth A. Gallo for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (nmg)
Jul 6, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Nicholas P. Groombridge, Eric Alan Stone, Kenneth A. Gallo, Jennifer Gordon, Ph.D., and David E. Cole filed by Genentech, Inc. Signed by Judge Gregory M. Sleet on 7/6/2017. (asw)
Jul 6, 2017	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric A. Stone for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Jul 5, 2017	13	Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 7/5/2017. (asw)
Jun 30, 2017	9	Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, with Jury Demand , COUNTERCLAIM against Baxalta GmbH, Baxalta Incorporated by Genentech, Inc..(Balick, Steven)
Jun 30, 2017	10	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (Balick, Steven)
Jun 30, 2017	11	Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas P. Groombridge, Eric Alan Stone, Kenneth A. Gallo, Jennifer Gordon, Ph.D., and David E. Cole - filed by Genentech, Inc.. (Balick, Steven)
Jun 30, 2017	12	Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (Mayo, Andrew)
Jun 20, 2017	8	Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Baxalta Incorporated, Baxalta GmbH: For Chugai Pharmaceutical Co., Ltd. waiver sent on 6/15/2017, answer due 9/13/2017. (Connolly, Colm)
Jun 2, 2017	N/A	Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Chugai Pharmaceutical Co., Ltd. on 6/2/2017. (nmg)
Jun 1, 2017	2	Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	3	Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	1	Main Document (12)
Jun 1, 2017	4	Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	1	Exhibit A (116)
Jun 1, 2017	5	Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	2	Exhibit B (5)
Jun 1, 2017	6	Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	3	Exhibit C (7)
Jun 1, 2017	4	Exhibit D (6)
Jun 1, 2017	5	Exhibit E (2235)
Jun 1, 2017	6	Exhibit F (26)
Jun 1, 2017	7	Exhibit G (188)
Jun 1, 2017	6	Return of Service Executed (2)
Jun 1, 2017	8	Exhibit H (179)
Jun 1, 2017	9	Exhibit I (3)
Jun 1, 2017	10	Exhibit J (4)
Jun 1, 2017	11	Exhibit K (4)
Jun 1, 2017	12	Exhibit L (3)
Jun 1, 2017	13	Exhibit M (13)
Jun 1, 2017	14	Civil Cover Sheet (2)
Jun 1, 2017	1	Main Document (12)
Jun 1, 2017	1	Exhibit A (116)
Jun 1, 2017	2	Exhibit B (5)
Jun 1, 2017	3	Exhibit C (7)
Jun 1, 2017	4	Exhibit D (6)
Jun 1, 2017	5	Exhibit E (2235)
Jun 1, 2017	6	Exhibit F (26)
Jun 1, 2017	7	Exhibit G (188)
Jun 1, 2017	8	Exhibit H (179)
Jun 1, 2017	9	Exhibit I (3)
Jun 1, 2017	10	Exhibit J (4)
Jun 1, 2017	11	Exhibit K (4)
Jun 1, 2017	5	Main Document (1)
Jun 1, 2017	12	Exhibit L (3)
Jun 1, 2017	1	Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	13	Exhibit M (13)
Jun 1, 2017	2	Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	14	Civil Cover Sheet (2)
Jun 1, 2017	3	Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	4	Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	5	Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	6	Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	4	Disclosure Statement (2)
Jun 1, 2017	5	Main Document (1)
Jun 1, 2017	1	Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice (1)
Jun 1, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [7] STIPULATION TO EXTEND TIME by which defendant Genentech, Inc. must answer, move, or otherwise respond to the complaint to June 30, 2017, filed by Genentech, Inc., Set/Reset Answer Deadlines: Genentech, Inc. answer due 6/30/2017. Ordered by Judge Gregory M. Sleet on 6/1/2017. (mdb)
Jun 1, 2017	7	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME by which defendant Genentech, Inc. must answer, move, or otherwise respond to the complaint to June 30, 2017, - filed by Genentech, Inc.. (Balick, Steven)
May 22, 2017	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer M. Dienes,Maria E. Doukas for Baxalta GmbH,Jennifer M. Dienes,Maria E. Doukas for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
May 16, 2017	N/A	SO ORDERED (0) Docket Text: SO ORDERED - re [5] MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow filed by Baxalta GmbH, Baxalta Incorporated. Ordered by Judge Gregory M. Sleet on 5/16/2017. (mdb)
May 16, 2017	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amanda S. Williamson for Baxalta GmbH,Amanda S. Williamson for Baxalta Incorporated added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
May 12, 2017	6	Return of Service Executed (2) Docket Text: Return of Service Executed by Baxalta Incorporated, Baxalta GmbH. Genentech, Inc. served on 5/11/2017, answer due 6/1/2017. (Connolly, Colm)
May 11, 2017	N/A	Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Genentech, Inc. on 5/11/2017. (sar)
May 11, 2017	5	Motion for Leave to Appear Pro Hac Vice (Main Document) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # (2) Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # (3) Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # (4) Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # (5) Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # (6) Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm)
May 11, 2017	5	Motion for Leave to Appear Pro Hac Vice (Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # (2) Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # (3) Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # (4) Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # (5) Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # (6) Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm)
May 11, 2017	5	Motion for Leave to Appear Pro Hac Vice (Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # (2) Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # (3) Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # (4) Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # (5) Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # (6) Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm)
May 11, 2017	5	Motion for Leave to Appear Pro Hac Vice (Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # (2) Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # (3) Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # (4) Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # (5) Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # (6) Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm)
May 11, 2017	5	Motion for Leave to Appear Pro Hac Vice (Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # (2) Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # (3) Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # (4) Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # (5) Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # (6) Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm)
May 11, 2017	5	Motion for Leave to Appear Pro Hac Vice (Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # (2) Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # (3) Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # (4) Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # (5) Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # (6) Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm)
May 11, 2017	5	Motion for Leave to Appear Pro Hac Vice (Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Abernathy, Christopher J. Betti, Amanda S. Williamson, Jennifer M. Dienes, Maria E. Doukas and Jessica A. Stow - filed by Baxalta GmbH, Baxalta Incorporated. (Attachments: # (1) Michael Abernathy Certification by Counsel to be Admitted Pro Hac Vice, # (2) Christopher J. Betti Certification by Counsel to be Admitted Pro Hac Vice, # (3) Amanda Williamson Certification by Counsel to be Admitted Pro Hac Vice, # (4) Jennifer Dienes Certification by Counsel to be Admitted Pro Hac Vice, # (5) Maria Doukas Certification by Counsel to be Admitted Pro Hac Vice, # (6) Jessica Stow Certification by Counsel to be Admitted Pro Hac Vice)(Connolly, Colm)
May 10, 2017	N/A	Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)
May 4, 2017	4	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Shire plc for Baxalta Incorporated; Corporate Parent Baxalta Incorporated for Baxalta GmbH filed by Baxalta GmbH, Baxalta Incorporated. (rwc)
May 4, 2017	1	Complaint* (1)
May 4, 2017	N/A	No Summons Issued (0) Docket Text: No Summons Issued. (rwc)
May 4, 2017	1	Complaint (Main Document) (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit A) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit B) (5) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit C) (7) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit D) (6) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit E) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit F) (26) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit G) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit H) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit I) (3) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit J) (4) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit K) (4) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit L) (3) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Exhibit M) (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	1	Complaint (Civil Cover Sheet) (2) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT AND DECLARATORY JUDGMENT OF PATENT INFRINGEMENT - filed with Jury Demand against Chugai Pharmaceutical Co., Ltd., Genentech, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2134340.) - filed by Baxalta Incorporated, Baxalta GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Civil Cover Sheet)(rwc)
May 4, 2017	2	Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc)
May 4, 2017	3	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,033,590. (rwc)

Lawsuits

Baxalta Incorporated et al v. Genentech, Inc. et al > Documents